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ABSTRACT 
Hollingshead, Nicole A. M.S., Purdue University, December 2013. An Investigation of 
Medical Trainees’ Self-Insight into their Chronic Pain Management Decisions. Major 
Professor: Adam T. Hirsh. 
 
 
 
While the majority of chronic pain patients report receiving inadequate care, 
there is evidence that female and Black patients receive less analgesic medications and 
treatment for their chronic pain compared to male and White patients, respectively. 
While treatment disparities have been evidenced in the literature, there is little 
understanding of provider-factors, such as their decision-making awareness and 
attitudes, which may contribute to the differences in treatment. This investigation 
employed quantitative and qualitative procedures to examine the relationship between 
patient demographics and chronic pain treatment variability, providers’ awareness of 
these non-medical influences on their decisions, and the extent to which providers’ 
gender and racial attitudes associate with their treatment decisions. Twenty healthcare 
trainees made pain treatment decisions (opioid, antidepressant, physical therapy, pain 
specialty referral) for 16 computer-simulated patients presenting with chronic low back 
pain; patient sex and race were manipulated across vignettes. Participants then selected 
among 9 factors, including patient demographics, to indicate which factors influenced 
their treatment decisions for the simulated patients and completed gender and racial 
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attitude measures. After online study completion, follow-up semi-structured interviews 
were conducted to discuss the medical/non-medical factors that influence trainees’ 
clinical treatment decisions. Quantitative analysis indicated that 5%-25% of trainees 
were actually influenced (p<0.10) by patient sex and race in their treatments, and on the 
whole, trainees gave higher antidepressant ratings to White than Black patients (p<.05). 
Fifty-five percent demonstrated concordance, or awareness, between their actual and 
reported use of patient demographics. Follow-up McNemar’s test indicated trainees 
were generally aware of the influence of demographics on their decisions. Overall, 
gender and racial attitudes did not associate with trainees’ treatment decisions, except 
trainees’ complementary stereotypes about Black individuals were positively associated 
with their opioid decisions for White patients. During qualitative interviews, aware and 
unaware trainees discussed similar themes related to sex and racial/ethnic differences 
in pain presentation and tailoring treatments. We found that (1) a subset of trainees 
were influenced by patient sex and race when making chronic pain treatment decisions, 
(2) trainees were generally aware of the influence of patient demographics, and (3) 
trainees discussed differences in pain presentation based on patients’ sex and ethnic 
origin. These findings suggest trainees’ are influenced by patient demographics and hold 
stereotypes about patient populations, which may play a role in their decision-making. 
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CHAPTER 1. INTRODUCTION 
 
1.1 
There are inconsistent findings suggesting that female and Black patients receive 
less optimal pain management than male and White patients, respectively. While 
provider-related factors have been hypothesized in the literature, few investigations 
have examined how these factors may influence providers’ chronic pain management. 
After providing an overview of chronic pain and treatment disparities, I outline the role 
that provider-related factors (e.g., awareness of decision-making influences, gender and 
racial attitudes) may play in influencing chronic pain treatment decisions. 
Introduction 
 
1.2 
Chronic pain afflicts 116 million people in the United States, with healthcare 
costs estimated between $560-635 billion dollars (1). The number of individuals 
experiencing chronic pain exceeds the number of people with cancer, heart disease and 
diabetes combined (
Chronic pain 
1). Pain is the number one reason why individuals seek healthcare, 
accounting for 80% of all physician visits (2). Seventy-one percent of chronic pain 
sufferers report having seen a physician or other medical professional in the past month, 
with many patients reporting their pain is undertreated (3).  
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 Pain is an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage (4). Acute pain is 
relatively brief, typically has a clear etiology, and is usually treated with pharmacological, 
physical and surgical treatments, which have high success rates for relieving pain (5). 
Chronic pain is prolonged and persistent pain experienced for at least three months and 
is often unsuccessfully treated with physical and medical treatments (5).  Acute pain 
care primarily requires attention to the sensory components of pain, such as intensity, 
location and temporal characteristics (6). However, in the treatment of chronic pain, 
additional attention should be devoted to psychosocial and behavioral factors, as 
chronic pain is often associated with psychological distress and disability (2, 6). Chronic 
pain may stem from a physical source, but the pain experience and resulting disability 
often become disproportionate to the original presenting problem (5).  
 Chronic pain is commonly understood through the biopsychosocial model. 
Dualistic conceptualizations that the mind and body function separately and 
independently do not sufficiently recognize the importance of psychosocial factors on 
the experience of physical problems (2); such recognition is particularly important for 
chronic pain. The biopsychosocial model focuses on the complex interaction of 
biological, psychological and social factors (2). Based on this model, chronic pain is 
optimally managed by focusing on restoring patient functioning through the integration 
of physical and psychosocial factors related to pain (5). This is reflected in numerous 
clinical guidelines, which recommend treating chronic pain with pharmacological (e.g., 
opioids, NSAIDS, antidepressants) and non-pharmacological treatments (e.g., physical 
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therapy, diet/exercise; 7, 8-12). Nevertheless, treatment recommendations vary across 
guidelines (13, 14), and perhaps because of this complexity, chronic pain patients often 
report poor pain management (3). 
 
1.3 
Currently there is a lack of training for chronic pain management in medical 
schools and residency programs in the United States. A 2011 survey of 104 US medical 
schools found that only 48 taught chronic pain, with an average of 0.5 lecture hours 
spent on this topic (
Medical training for chronic pain treatment 
15). This is striking given the prevalence of chronic pain and 
treatment utilization estimates (1-3).  
This lack of training translates into a skill deficiency for providers. Across all 
specialty areas, graduating residents report feeling unprepared to treat chronic pain 
patients due to inadequate training (16). A survey of Internal Medicine and Family 
Medicine residents across US programs reported low levels of preparedness to treat low 
back pain (17). Chronic pain training deficiencies are not addressed after residency, with 
half of primary care physicians sampled reporting they felt “somewhat prepared” to 
counsel their patients about pain and a quarter felt “somewhat unprepared” or “very 
unprepared” (1, 18).  Furthermore, physicians report insufficient training in opioid use 
as a barrier to following pain management guidelines (19).  
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1.4 
Although healthcare providers see a higher percentage of chronic than acute 
pain, they report feeling less confident, less satisfied with patient interactions, and 
setting lower goals for chronic pain management than other types of pain (
Difficulties in treating chronic pain 
20). Sampled 
providers describe working with chronic pain as “frustrating” as they believe patients 
will never achieve pain relief (21-23). Chronic pain treatment is further complicated due 
to providers’ fears of patients becoming dependent on or abusing opioid medications 
(24). Negative attitudes about chronic pain and some of its treatments result in provider 
suspicion of pain reports (21, 22).  
When no clear etiology or source of pain is present, as is often the case with 
chronic pain, healthcare professionals rely primarily on patients’ subjective reports (1, 
18, 25). These reports vary based on the psychosocial factors experienced by each 
patient (8). Communication of the pain experience is often challenging as the patient 
and provider may have different languages, experiences, expectations, and frames of 
reference that influence their pain perception (6).  
Medical providers and trainees report the subjective nature of pain complicates 
treatment decisions, especially when no objective pain source is identified (26).  
Healthcare providers often view chronic pain as a symptom of underlying pathology, 
rather than a primary problem deserving of treatment on its own right (1, 6).  This is 
evidenced by providers extensively searching for an objective source of pain, resulting in 
patients being over-imaged and over-diagnosed (5). This diagnostic pursuit increases the 
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likelihood of false-positive tests, commonly leading to an inaccurate diagnostic label 
that may be difficult to remove and contribute to the mismanagement of pain (5).  
The lack of objective evidence is one reason why healthcare providers hold 
negative attitudes and misconceptions about chronic pain and its treatment (27). For 
instance, healthcare providers have been shown to use more sympathetic language and 
acknowledge patient suffering when pathology of pain has been identified than when 
no clear cause has been identified (21). The compounding factors of insufficient training 
and treatment difficulties result in pain assessment and treatment decisions that are 
vulnerable to provider attitudes and non-medical patient factors (28). 
 
1.5 
Patient demographic characteristics have been shown to influence pain 
assessment (
Treatment disparities evidenced in pain management 
29-35), which may result in suboptimal pain management and health 
disparities for certain patient populations. Health disparities are defined as differences 
in health outcomes and treatments between segments of the population, typically 
based on demographic attributes (36).  Disparities have been reported in the literature 
for female and Black chronic pain patients. 
 
1.5.1 Treatment disparities for female chronic pain patients 
Women are more likely to report experiencing pain than men, with an increased 
prevalence of multiple pain syndromes (37-41). However, fewer women have adequate 
pain management as compared to men (42). For both acute and chronic pain, women 
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are more likely than men to receive a non-specific, somatic diagnosis and be treated less 
extensively for their pain, even when presenting with the same severity of symptoms 
(43, 44). For example, Safdar et al. (2009) found that male patients were more likely to 
be administered opioid medication in the emergency room than female patients 
experiencing either acute or chronic pain (45).  
Treatments may be influenced by providers’ beliefs that men and women 
experience pain differently. The differences between gendered and biological pain 
responses should be noted. Biological differences refer to the physiological differences 
between men and women, while gender differences refer to the social construction of 
gender roles assigned to individuals based on their presenting sex (46). There is some 
evidence to suggest that, biologically, women may be more sensitive to pain than men, 
and pain response may fluctuate based on their menstrual phase (38, 47, 48). However, 
there is inadequate empirical evidence supporting treating patients differently based on 
their biological sex (38, 49-53). Psychological and social variables related to gendered 
response of pain may explain more of the variance between men and women’s pain 
experience than biological differences (38, 54).  
Gender differences exist in the presentation of pain. Women often describe their 
pain in “non-specific” terms, such as reporting the psychological impact of pain and 
failing to report a source for their pain. Men more often attribute pain to an etiology 
and describe events surrounding pain (55). Women also are more likely to use 
catastrophizing as a coping mechanism (i.e., focusing on the most extreme negative 
consequence), which has been shown to predict higher levels of disability and poorer 
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quality of life (56-58). Gender differences in presentation may be part of the reason why 
women are more likely to receive a nonspecific, psychosocial diagnosis across a variety 
of health domains and are more likely to be treated with antidepressants than males (43, 
59). In fact, laypersons of both genders expect females to be more willing to report pain 
and be more sensitive to pain (37, 60-65). There is inadequate research regarding 
treatment differences between men and women for non-pharmacological pain 
treatments (e.g., physical therapy and referral to a pain specialist).  
 
1.5.2 Treatment disparities for Black chronic pain patients 
Pain treatment disparities exist between individuals of different races and 
ethnicities. While race and ethnicity are often the combined focus of health disparities 
literature, they are different constructs. Race refers to a person’s ancestry and is used to 
differentiate populations related by blood, common descent, or heredity (51). Ethnicity 
often encompasses race but also refers to characteristics related to social, psychological, 
cultural, and political aspects (66).  
Most of the literature on pain disparities has focused on race differences, with 
Black patients often reporting poorer pain management than White patients. Dobscha 
et al. (2009) found that Black patients were less likely to rate their chronic pain 
treatment as “very good” or “excellent” as compared to White patients (67).  Providers’ 
treatments are influenced by race, as there is evidence that Black patients receive fewer 
opioids than Whites for their pain (42, 68-74). Even when Black patients sampled had 
significantly higher chronic pain scores compared to Whites, they were less likely to be 
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prescribed opioid medications (75). Heins et al. (2006) found that White patients were 
1.8 times more likely to receive opioids than Black patients presenting with acute or 
chronic pain in the emergency department (76). Opioid treatment differences between 
Black and White patients exist even after controlling for age, pain site, socioeconomic 
status (SES), and insurance (74, 77).  
A relatively smaller literature also indicates that treatment disparities between 
Black and White pain patients expand beyond differences in opioid medications. A 
recent meta-analysis examining a variety of pain treatment types found that Black 
patients were undertreated across all analgesic medications (e.g., opioids and non-
opioid/nonsteroidal anti-inflammatory drugs [NSAIDS]) and were 22% less likely than 
White patients to receive any analgesic medications (78).  Retrospective chart-reviews 
of chronic and acute pain found Black pain patients received fewer analgesic 
medications and less aggressive management as compared to White pain patients (74, 
79, 80). These treatment disparities were not explained by differences in symptom 
severity as Black patients sampled reported similar, and in some cases greater, pain 
levels than White patients (79, 80); these results suggest that treatment differences are 
not explained by providers’ inability to accurately assess pain severity across patient 
race (81). A survey of chronic pain patients found White patients were more likely than 
Black patients to report receiving physical therapy (PT); however, it is unclear if this 
difference is a result of providers recommending PT less for Black patients or patient-
related factors (e.g., access to PT; 75). This same chronic pain survey found no racial 
difference in utilization of a pain specialist (75). There is inadequate research regarding 
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treatment disparities for antidepressant medication for pain management; however, 
Black patients have been found to receive less antidepressant prescriptions than White 
patients for depression (82).  
The under-treatment of pain is striking given that Black individuals are more 
likely to experience pain and to face resulting decreased quality of life and disability (83-
87). There is some evidence to support that Blacks have lower pain tolerance than 
Whites (65); however, the pain response has been shown to be mediated by high rates 
of chronic stress that Blacks face due to discrimination (88). Access barriers exist for 
Black chronic pain patients with one out of five Black individuals classified as uninsured 
and living below the federal poverty line (36). This decreased access to care results in 
higher rates of poor general health, which has been shown to moderate pain tolerance 
and the pain experience (58, 89). These findings are contrary to laypersons’ perceptions 
that the typical Black person is less sensitive to pain and less willing to report pain than 
the typical White person (65). Every day stressors, cultural misconceptions, and 
decreased access to care, may account for higher rates of disability and poorer 
functioning for Black chronic pain patients (85, 90). Further research is needed to 
understand why Black chronic pain patients receive less adequate pain management as 
compared to White patients.  
 
1.6 
The aforementioned research on sex and race disparities in pain management 
has been largely observational in nature. There are few true experimental studies that 
Influence of patient demographics on decision-making 
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manipulate patient variables to determine their influence on pain management 
decisions. Across several vignette studies, the most influential factors on pain 
assessment were patient-reported pain intensity and facial expression of pain (31, 32, 
34, 35). Nevertheless, there is evidence from experimental studies that providers use 
other factors, including patient demographics, when making pain assessment ratings (29, 
30, 32-35). Numerous vignette studies have found that both laypersons and healthcare 
providers rate female patients as experiencing higher pain intensity (29, 31, 32, 34, 35), 
greater pain unpleasantness (29, 31, 32, 34), more negative mood (29, 31, 34), and 
poorer coping than male patients (29, 31, 34). In these studies, Black patients were 
rated as having higher pain intensity (32, 34, 35), more pain unpleasantness (32, 34), 
and better coping (29) than White patients. Patient sex and race accounted for between 
0% and 23% of the variance in laypersons’ and nurses’ pain assessment decisions (32, 
34). Several of these studies also found considerable individual variability in both the 
size and direction of these effects, suggesting a need for additional research to better 
understand the provider factors that are associated with pain decision-making for 
diverse patients.   
Although patient demographic influences on providers’ pain perceptions have 
been cited in the literature, there are few experimental studies investigating the extent 
of sex and race influence on different treatment decisions for pain management. 
Vignette studies found that laypersons and healthcare trainees were more likely to 
recommend medical help for female and Black patients experiencing chronic pain (31, 
32, 34, 35); however, “medical help” was not further clarified. Two other studies used 
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true experimental methods to manipulate patient sex and race in order to examine the 
extent of patient demographics’ influence on specific pain treatments. Tamayo-Sarver et 
al. (2003) found physicians were not influenced by vignette patients’ race/ethnicity 
when recommending opioid treatment for patients presenting with either acute or 
chronic pain (70). However, this investigation presented participants with only 3 text-
based vignettes (1 White, 1 Black, 1 Hispanic) and did not examine other commonly 
used analgesic medications, which calls into question the ecological validity and 
generalizability of their findings. Hirsh, George, & Robinson (2009) found that nurses 
were influenced by vignette patient sex and race when deciding to administer an opioid 
or a non-opioid treatment for acute pain, with more nurses being influenced by patient 
demographics for opioid treatments. On average, these nurses were more likely to 
prescribe an opioid medication to female and Black patients than male and White 
patients with acute pain (32). Individual differences in the size of these effects were 
again observed. For some nurses, the sex and race influences were substantial – 
accounting for as much as 30% of the variance in treatment ratings – whereas for others, 
these factors did not significantly influence their decisions (32). Moreover, these results 
differ from those of several observational studies reviewed previously. Further research 
examining patient sex and race influence on chronic pain treatment decisions may help 
account for this individual variability and clarify some of these contradictory findings.  
Given the public health significance of chronic pain in the US, as well as the 
(somewhat inconsistent) findings of sex and race disparities in pain treatment, further 
investigation of patient sex and race influences on chronic pain management is needed. 
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Research is also needed to better understand how provider factors, such as their 
attitudes and decision-making awareness, influence their clinical decisions for diverse 
patients. Investigation into the provider factors that contribute to treatment disparities 
will enhance understanding of clinical decision-making and inform chronic pain training 
curricula.  
 
1.7 
In order to understand factors that may contribute to treatment disparities, it is 
important to understand how healthcare providers and trainees make clinical decisions. 
Social Judgment Theory (SJT) provides a framework for understanding the process of 
clinical decision-making (91-93). Research using SJT has found clinicians make decisions 
differently than they report, which suggests they lack full awareness about their clinical 
decision-making process (33, 92, 93). According to SJT, most clinical decisions are quasi-
rational judgments, which is an area in a theoretical judgment spectrum that lies 
between analytic judgments (i.e., judgments are certain; based on known rules and 
application of knowledge) and judgments based on intuition (i.e., judgments are 
uncertain; influenced by numerous factors and each decision has many possible 
outcomes; 93). SJT is well-suited for providing insight into these quasi-rational 
judgments as it recognizes that a decision is rarely fully informed and is based on 
multiple variables and information (94).  
Social Judgment Theory 
This theory proposes that there are differences in the way that healthcare 
providers use information to guide decisions (93). Providers’ decisions are guided by 
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multiple sources of available information (termed proximal cues in the SJT framework; 
94). For example, Wigton (1996) observed that the decision to prescribe an antibiotic for 
a patient’s sore throat involved fifteen cues, such as fever, swollen nodes on neck, and 
patient preference for treatment. The influence of these proximal cues on providers’ 
decisions will vary between contexts and providers; this influence is determined by a 
provider’s attention to and weighing of the information presented in the environment 
(93, 94).  Thus, different providers may make different decisions for the same clinical 
situation (93, 94).  
Even when established treatment guidelines are available, research has shown 
that there is a wide variation in healthcare providers’ decisions and information used to 
inform their judgments (92).  In a vignette study, Smith, Gilhooly & Walker (2003) found 
that patients presenting with or without several symptoms of depression elicited 
considerable individual variability in physicians’ prescription of an antidepressant (91). 
Low levels of agreement indicate either little consensus about best treatment or that 
decisions are more dependent on clinicians’ idiosyncratic habits and preferences (91). 
These idiosyncrasies between providers have not been fully identified, but would 
provide further information regarding influences on provider treatment decisions in 
general and for chronic pain management in particular. As clinicians are often unsure 
about the optimal treatment of chronic pain (20), it is important to understand how 
clinicians’ own predispositions may be guiding chronic pain treatment decisions.  
Further insight into providers’ decision-making process may help clarify the role 
of patient demographics in chronic pain management. As evidenced by previous work in 
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this area [see Hirsh, George & Robinson (2009)] and the tenets of SJT, not all healthcare 
providers sampled will be influenced by patient sex and race. Moreover, the nature of 
these influences may differ across providers. Thus, it may be beneficial to examine 
provider factors that are hypothesized to play a role in this context, such as providers’ 
awareness of their decision-making process and their attitudes about sex and race.  
 
1.8 
A recent review of the literature revealed a gap in identifying factors that 
contribute to treatment disparities and noted the need to better understand clinical 
decision-making and the role of stereotyping and bias (
The role of awareness and attitudes on clinical decisions 
28). A better understanding of 
how providers’ decision-making and attitudes may contribute to health disparities can 
highlight areas for training to help diminish these differences (43).  
 
1.8.1 Role of providers’ awareness 
Few studies on clinical decisions have investigated providers’ awareness of their 
own decision-making process (for the purpose of this document, I will use the terms 
“self-aware” and “self-awareness” to refer specifically to awareness of the factors that 
influence providers’ decisions). Self-awareness is an important quality in a provider as it 
better equips them to compare their decisions to social norms and guidelines (95).  
Self-aware providers may be more inclined to tailor interventions based on 
patients’ sex or race (96). For instance, opioid clinical guidelines recommend treatment 
should not be tailored based on patient sex alone (8); however, there is some emerging 
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evidence suggesting women may require different levels of and respond differently to 
some opioids than males (51, 52). Providers who are familiar with these findings may be 
knowingly influenced by patient sex when making decisions about opioid medications 
for chronic pain. Moreover, focus groups found some physicians reported using race as 
a central factor to help guide their decisions for diabetes and hypertension treatments 
(97). These findings should not be overstated, however, as providers’ reported use of 
sex and/or race may not coincide with the actual influence of these patient 
demographics on their decisions.  
Few published studies have measured healthcare providers’ level of awareness 
for their pain-related decisions. Two studies found that nurses were aware of using 
patients’ facial expressions to guide acute pain management decisions, but there was 
mixed awareness regarding the use of patient demographics (33, 98). Hirsh, Jensen, and 
Robinson (2010) found none of the nurses sampled reported using patient sex, race, 
and/or age when making acute pain management decisions, but judgment analysis 
revealed between 13% and 31% of participants actually used one of these variables in 
their decision-making process. Edwards et al. (2002) found 61% of nurses reported using 
“patient characteristics” when making a decision to administer an opioid (98); however, 
this broad categorization could be interpreted by participants as encompassing more 
than just patient demographics. Moreover, as evidenced by Hirsh, Jensen, and Robinson 
(2010), self-reports may not always equate with actual use of patient characteristics in 
the decision to administer an opioid or other treatment. As Edwards et al. (2002) note  
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in their study limitations, reports may be influenced by socially desirability (98). The 
inclusion of both self-report and a measure of actual use of patient characteristics will 
help clarify providers’ level of awareness.  
Further research is needed to better understand providers’ level of awareness of 
the influence of patients’ sex and race on their pain management decisions. Given the 
lack of empirical literature, it remains unclear if providers’ awareness of demographic 
influence is associated with the quality of their pain management for certain patient 
populations. Some providers may knowingly use patients’ sex and race in their 
treatment decisions to provide culturally centered care or to fit with stereotypes about 
patient populations; however, further investigation is necessary. Continued examination 
of provider awareness may improve patient care and inform chronic pain education. 
 
1.8.2 Providers’ attitudes 
As providers have described treating chronic pain as “frustrating” (21, 22, 99) 
there is a possibility that providers’ attitudes may contribute to chronic pain patients’ 
reports of inadequate pain management (3).  An attitude is a favorable or unfavorable 
learned response that helps individuals make sense of the world, and can guide 
cognitive and/or behavioral responses in a given environment or situation (100). 
Although the attitude-behavior relationship is still widely discussed in the literature, 
evidence suggests that when certain conditions are met (e.g., attitude is relevant to a 
situation), attitudes are more likely to influence behavior (101). 
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Healthcare providers’ attitudes have been shown to be related to their pain 
management decisions. There is evidence that nurses and physicians hold cautious 
attitudes about opioids, and these attitudes were associated with lower intentions to 
administer opioids (19, 23, 98). Bishop et al. (2008) found physician attitudes about low 
back pain guided treatment decisions even when they deviated from treatment 
guidelines (102). Furthermore, physiotherapy students’ attitudes regarding low back 
pain were predictive of activity advice and treatment approach (103).  
 
1.8.2.1 
Providers’ gender- and race-biased attitudes could be one reason why women 
and Black chronic pain patients are at increased risk for suboptimal pain management 
compared to male and White patients (
Influence of gender and racial attitudes on chronic pain treatment decisions 
42, 67). The MODE model (“motivation and 
opportunity act as determinants of spontaneous versus deliberative attitude-to-
behavior processes”) has been used as a guiding framework in previous investigations to 
examine how biased attitudes may influence behavior. This model suggests individuals 
use a conscious and deliberate process to weigh the costs of acting in accordance with 
ones’ attitudes. Individuals are more likely to be influenced by gender- and racially-
biased attitudes when motivation is decreased (e.g., consequences of making a wrong 
decision are minimal) and there is little opportunity (e.g., minimal time or increased 
cognitive load) to reflect on their attitudes (101, 104). As providers have expressed 
suspicion of patient pain reports, believe chronic pain patients rarely achieve significant 
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pain relief, and have little time to deliberate in clinical settings (21, 24, 105), providers 
with gender- and racially-biased attitudes may lack the necessary motivation and 
opportunity to consider the influence of their biased attitudes prior to treating female 
and Black chronic pain patients.   
There is some evidence that providers’ gender attitudes may result in 
inadequate pain management in women. Hoffman and Tarzian’s (2001) review of the 
pain literature suggested that female pain reports were more likely to be attributed to 
psychological sources than male reports of pain (59). This was supported by subsequent 
vignette studies, which found healthcare providers rate female pain patients as 
experiencing more negative mood than males and perceive male patients’ pain as more 
urgent, severe, and disabling than females (30, 106). Hamberg, Risberg, Johansson, and 
Westman (2002) found gender differences in clinical communication when assessing 
acute pain, with medical students asking female patients about family aspects and male 
patients about occupational aspects of the pain experience (107). Furthermore, 
healthcare providers have expressed negative attitudes about the discussion of 
psychological contributions of pain (21). This is important in the context of pain 
disparities, due to evidence that females tend to use emotional-based descriptions of 
pain more than males. Moreover, although depression diagnosis and antidepressant 
treatment is more common in women than men, there is some evidence that biased 
gender attitudes may contribute to over-diagnosis of depression in women (59, 108). 
Taken together, these factors may lead to an inaccurate diagnosis of depression or 
personality disorder in female pain patients (109).  
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Healthcare providers’ attitudes regarding women’s gender roles may contribute 
to suboptimal pain management in female patients (96); however, few studies have 
actually measured healthcare providers’ gender attitudes. Medical students surveyed 
predominately expressed “liberal” attitudes on a socio-cultural measure that included 
questions about gender roles; however, this same measure included items unrelated to 
gender attitudes (e.g., openness to alternative medical treatments; 21). Hatala and Case 
(2000) found that medical students had worse diagnosis accuracy for female patient 
cases than males, which the authors proposed was due to gender bias, yet, no measure 
of attitudes was used in the study design (110). To better understand the role of 
healthcare providers’ gender attitudes on pain treatment decisions, it is critical that 
providers’ attitudes be assessed directly with reliable and valid measures. 
Although gender attitudes are scarcely measured in the literature, there is 
evidence to support that healthcare providers hold racially biased attitudes. Healthcare 
providers have been shown to hold a preference for White over Black individuals (111-
114), even more so than the general public (113). Furthermore, it has been suggested 
that racial stereotyping from healthcare providers may influence their pain 
management decisions (115). Healthcare providers and trainees are often cautious 
when providing patients with opioids because of the risk of drug abuse (19, 23, 99, 112, 
115). Epidemiologic data and mainstream portrayals of Black individuals may lead 
providers to develop negative attitudes regarding Black patients’ potential misuse of 
medications (99, 112, 115-117). These “evidence-based” stereotypes may serve to 
reinforce providers’ decisions to treat Black chronic pain patients differently than White 
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patients; however, there is evidence that these population statistics are over-applied to 
individual patients (115). Furthermore, these statistics may be misleading as there is 
evidence that racial minorities are actually less likely to abuse prescription medicine (36).  
There is some evidence that healthcare providers hold explicit negative racial 
attitudes toward Black individuals. Explicit attitudes are self-reported attitudes that are 
known or can be readily accessed by the individual (118). According to the MODE model, 
explicit attitudes are more likely to be displayed through a person’s verbal behavior, 
particularly when motivation and opportunity to inhibit the influence of their attitudes 
is low (119). A national survey of explicit racial attitudes found providers preferred 
White over Black individuals at rates greater than the general public (113). To the 
author’s knowledge, only two previous vignette studies examined providers’ explicit 
racial attitudes and their relationship to treatment decisions. Green et al. (2007) and 
Sabin, Rivara, & Greenwald (2008) found providers did not report explicit racial 
preference, and their attitudes did not influence treatment decisions. However, these 
investigations did not use a validated measure of explicit attitudes; instead, participants 
answered two questions regarding if they “slightly preferred” White or Black individuals 
on a 5 point scale and rated their feelings towards Whites and Blacks on a 10 point 
thermometer from “cold” to “warm.” Furthermore, one investigation administered the 
explicit attitude measure after an implicit racial attitude measure, which the authors 
acknowledged as a limitation that may have lead providers’ to report socially desirable 
explicit attitudes (120).  
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Research also suggests providers’ implicit racial attitudes (attitudes that may or 
may not be readily apparent to the individual, that are often automatically and 
unintentionally activated, and are more likely to predict non-verbal behavior) may 
influence their treatment decisions (118). Physicians have been found to hold implicit 
attitudes that Black patients are less cooperative and less compliant than White patients 
(116, 120). In a vignette study, residents were shown to hold an implicit preference for 
Whites and had a decreased likelihood of treating Black patients presenting with 
thrombolysis (116). However, two other vignettes studies found pediatricians and 
medical students also held an implicit preference for Whites, but these attitudes did not 
translate into pain assessment or treatment differences (114, 120).  
As there is some indication that providers hold gender and racial bias, and that 
these attitudes may influence their treatment decisions, additional research is needed 
to better understand the role of these attitudes in chronic pain management decisions. 
Explicit attitudes, in particular, have the potential to be addressed and altered through 
training in order to reduce their impact on patient care (121). Future examination of 
these relationships may inform educational efforts that reduce biased attitudes and 
their influence on clinical decisions.  
 
1.9 
Enhanced understanding of how healthcare providers make decisions and how 
provider factors impact their treatment decisions may help to diminish chronic pain 
treatment disparities. A review of the pain disparities literature specifically calls for 
Mixed methods 
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research to better understand clinical decision-making and the role of provider 
stereotyping, while using techniques that allow for greater generalizability of findings 
(28). Mixed methods designs may be particularly useful in this research, as these designs 
are often better able to capture the multi-faceted nature of chronic pain management 
decision-making.  
Mixed methods designs have received increasing attention and support in the 
literature (122-124). While previous conceptualizations considered qualitative and 
quantitative examinations to be dichotomous, many argue that mixed methods have 
been used since the proposal of the multi-trait multi-matrix (MTMM) by Campbell and 
Fiske in 1959, and that the majority of scientific findings are often based on multiple 
sources and types of data (123, 124). Mixed methods are particularly useful in 
healthcare research as they draw upon the strengths and perspectives of each method 
to capture the wide-range of influences present in a clinical setting (124). Mixed 
methods designs have also been recently identified by the NIH as able to improve the 
quality of disparities research by providing real-life contextual understanding and multi-
level perspectives (125). With this in mind, I contend that quantitative lens model 
designs and qualitative interview data collectively can increase our understanding of 
clinical decision-making for pain management.   
 
1.9.1 Lens model 
Lens model designs are well-suited to increasing our understanding of disparities 
in clinical decision-making, as they provide a quantitative estimate of the influence of 
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patient factors, such as sex and race, on providers’ clinical decisions (92). The lens model 
assumes that judgments are contextually determined and based on an individuals’ 
attention to- and weighing of multiple pieces of information available in the 
environment (92, 126).  
Research using Social Judgment Theory framework supports the usefulness of 
the lens model as a powerful and important tool for studying clinical decision-making 
(92). Using this methodology, researchers are able to calculate the level of influence of 
each variable of interest, or “cue,” on each decision. Importantly, this influence is 
calculated while holding unmeasured variables constant, so that the unique effect of 
each systematic change in cue is determined (e.g., an influence of patient sex and/or 
race; (92, 126). Decisions are typically measured with visual analogue scales (VAS), 
which participants use to make ratings for each decision. For example, participants may 
rate their likelihood of giving a patient an opioid medication for pain on a scale of 
“highly unlikely” to “highly likely”. These ratings are then analyzed across cues in order 
to quantify the amount of influence of each cue across participants’ decisions (94, 126). 
Going back to the previous example, a participant may be less likely to give an opioid to 
female patients than male patients; therefore, the cue, “patient sex,” would be 
influential in the decision to administer an opioid. 
The lens model facilitates a better understanding of the factors that influence 
providers’ treatment decisions than traditional research designs, as it allows for 
analyses at the level of the individual provider (idiographic analyses) and overall sample 
(nomothetic analyses). An idiographic view of the data provides a quantitative estimate 
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of the influence of factors, such as patient sex and race, on each provider’s treatment 
decisions. Idiographic analysis provides a better understanding of the influence of 
hypothesized cues by examining cues for each participant before averaging data across 
participants at the group level (94). Individual analyses may uncover trends within cues 
of interest that are normally lost in traditional group analyses. For example, Smith et al. 
(2003) found that group-based analysis indicated that clinicians generally understood 
clinical guidelines for the treatment of depression; however, at the individual level it 
was revealed that individual clinician judgments exhibited considerable variability and 
ranged from “patient definitely should not be prescribed an antidepressant” to 
“guidelines indicate an antidepressant” for the same vignettes. Moreover, the cues of 
interest can function in opposite directions for different participants. For instance, some 
participants may be less likely to give female patients an opioid, while other participants 
may be less likely to give male patients an opioid. These differential cue influences are 
typically averaged out and lost in traditional group analyses, which may lead to the 
misleading conclusion that patient sex is not influential in pain management decisions. 
This averaging process may miss important individual differences in decision-making and 
may lead to suboptimal policy recommendations.  
To the author’s knowledge, only one previous vignette study of chronic pain has 
used lens model methodology to examine the influence of patient sex and race in 
healthcare trainees. Stutts, Hirsh, George, and Robinson (2010) found across 107 
healthcare trainees, female and Black chronic pain patients were rated as experiencing 
higher pain intensity, more pain unpleasantness, more negative mood, and requiring a 
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higher need for medical help than males and White patients. Similarly, idiographic 
review found 6-12% of trainees rated females higher and 2-7% of trainees gave higher 
ratings to Black patients across pain assessments. In contrast, other participants rated 
males and White patients higher across pain assessments. These findings highlight the 
fact that the direction of cue influence may vary across individual participants. 
This examination supports the use of both idiographic and nomothetic analyses 
to enhance understanding of clinical decision-making. In these studies, although group 
analysis indicated that different treatments were sometimes provided to male vs. 
female and White vs. Black patients among the overall sample of participants, 
idiographic review showed that only a subset of participants was significantly influenced 
by patient demographics when making decisions. Furthermore, individual analysis 
revealed variability in the direction of the influence of patient sex and race among the 
participants. To better understand treatment disparities for chronic pain, this 
methodology could be used to provide insight into the influence of patient 
demographics across various treatment types and individual participants. 
 
1.9.2 Qualitative methods 
A mixed-methods approach consists of integrating quantitative and qualitative 
data. Semi-structured interviews are a common form of qualitative data in which a 
structured, but flexible, interview guide is used that allows the interviewer to follow up 
with additional questions and probes, as needed (127). Completed interviews are 
examined by thematic analysis to identify, analyze, and report patterns within the 
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interviews (128). Parallel data analysis is a common approach for integrating qualitative 
and quantitative data. In this approach, the data sets are collected separately and then 
integrated once individual analyses are complete (122). In parallel analysis, qualitative 
data is used to provide further insight into little researched processes (125). Qualitative 
data can be used to highlight statistically significant findings by examining convergent 
evidence (qualitative and quantitative lead to the same conclusion), complementary 
evidence (qualitative and quantitative results supplement each other), and/or divergent 
evidence (qualitative and quantitative results are, at times, contradictory; 122).  
Two studies have used qualitative data to provide insight into providers’ 
treatment of chronic pain. In Matthias et al. (2010), interviewed providers stressed the 
importance of the patient-provider relationship and voiced common concerns in the 
treatment of chronic pain, such as pressure from medical centers and patients to treat 
pain with opioids, questioning the credibility of pain reports, and suspicion of drug 
diversion. Corrigan et al. (2011) found first-year medical students shared similar 
concerns after journaling about their first primary care rotation experience. The 
students noted the difficulty in treating chronic pain due to uncertain pain 
etiology/assessment and reported suspicion of patients being “untruthful or 
manipulative” to obtain opioids (105). To the author’s knowledge, no qualitative study 
has been published examining the influence of patient demographics on providers’ 
chronic pain assessment and treatment. 
Semi-structured interviews will provide a fuller picture of the influence of patient 
sex and race, as well as other factors, on chronic pain management decisions. Previous 
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examinations of clinical decision-making have been criticized for failing to account for 
social context, such as provider factors, practice setting, and healthcare systems 
information (28). An additional limitation of the chronic pain disparities literature is 
studies rarely consider patient factors that may affect decisions, such as SES or previous 
substance abuse history (115). Mixed-methods would likely provide a deeper 
understanding of the role of patient sex and race on treatment decisions, while also 
allowing providers’ the opportunity to discuss the role of other factors that may 
influence their chronic pain treatment decisions for diverse patients. Furthermore, 
mixed-methods may allow for a better understanding of provider factors that influence 
their chronic pain management decisions. Qualitative interview methodology may also 
enhance understanding of providers’ self-awareness of their own decision-making 
processes, as well as their attitudes towards treating chronic pain, in general, and 
female and Black chronic pain patients, specifically.  
 
1.10 
Chronic pain is a critical public health issue due to its high prevalence, healthcare 
costs, and management difficulties. Pain treatment disparities have been documented 
in the literature, with female and Black patients reporting worse pain management 
compared to male and White patients, respectively. While some evidence suggests 
healthcare providers and trainees are influenced by patient demographics when 
providing acute pain care, the influence of patient sex and race on chronic pain 
management decisions remains unclear. Furthermore, little is known about provider 
Purpose of this study 
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factors, such as their attitudes and decision-making awareness, which may contribute to 
differential pain care for female and Black chronic pain patients.  
 The current study was conceived to better understand the patient and provider 
factors that influence chronic pain treatment. This study uses a mixed-methods 
approach that integrates quantitative and qualitative data to examine the influence of 
patient sex and race on healthcare trainees’ treatment decisions. Trainee awareness of 
their treatment decisions will be examined by comparing the actual influence of patient 
demographics on treatment decisions, as captured by lens model methodology, with 
trainees’ self-reported factors (including patient demographics) that influence their 
decisions. Trainees’ gender- and racial-attitudes will also be assessed both quantitatively 
and qualitatively to examine their relationship with pain management decisions. The 
results of this mixed-methods approach may provide suggestions to improve patient 
care and chronic pain education.  
 
1.11 
This study used a mixed methods approach to examine: 1) the influence of 
patient sex and race on healthcare trainees’ pain management decisions; 2) trainees’ 
level of awareness of their decision-making process; and 3) the extent to which trainees’ 
gender- and racial-attitudes are associated with chronic pain decisions.  Twenty trainees 
made pain management decisions for 16 clinical vignettes of patients presenting with 
chronic pain that varied based on sex (Male or Female) and race (Black or White).  For 
each vignette, trainees rated their likelihood of recommending different pain treatment 
Study overview 
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types. After making treatment decisions, trainees reported which factors, including 
patient demographic characteristics, influenced their treatment decisions. Participants 
also completed standardized measures assessing their attitudes about gender and race. 
The quantitative data was analyzed with both individual and group-based statistics. To 
supplement participants’ quantitative data, qualitative interviews were conducted to 
gain a deeper understanding of how trainees make pain treatment decisions for diverse 
patients in clinical settings. These interviews will provide further insight into trainees’ 
awareness and attitudes about sex and race in the context of chronic pain management.  
 
1.11.1 Hypotheses 
Study hypothesis 1: Idiographic quantitative statistical analyses will indicate that 
a subset of healthcare trainees are significantly influenced by patient sex and race in 
their treatment decisions. Moreover, I hypothesize that when differences emerge at the 
nomothetic level of analysis, female and Black patients will receive significantly lower 
treatment ratings, (opioid, antidepressant [except in the case of female patients], 
physical therapy, and referral to a pain specialist), than male and White patients, 
respectively. 
Study hypothesis 2: Healthcare trainees will demonstrate little self-awareness 
about the influence of patient sex and race on their pain management decisions. 
Specifically, there will be little concordance between trainees’ actual use of 
demographics (measured during quantitative analysis) and their reported use of 
demographics during the quantitative and qualitative portions of this study.  
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Study hypothesis 3: Trainees’ gender- and racial-attitudes will be associated with 
their pain treatment ratings. Specifically, higher scores on the gender and race attitude 
measures (i.e., more negative attitudes about women and Blacks, respectively) will be 
associated with lower opioid ratings for female and Black patients (relative to male and 
White patients, respectively), and higher scores on the gender attitude measure will be 
associated with higher antidepressant ratings for female patients (relative to males). 
Given the insufficient literature on disparities for other commonly used treatments for 
chronic pain, I propose no hypotheses about the relationship between trainees’ racial-
attitudes and likelihood to recommend an antidepressant nor trainees’ gender- and 
racial-attitudes and likelihood to recommend physical therapy or referral to a pain 
specialist. Should patient sex or race account for a significant amount of the variance in 
providers’ treatment decisions, gender and racial attitudes will be examined as potential 
mediators/confounders of this observed relationship. 
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CHAPTER 2. METHODS 
 
2.1 
This investigation was a secondary analysis of a larger study that recruited various 
healthcare providers, such as physicians and nurses. Healthcare providers were 
recruited to participate in both the quantitative and qualitative portion of this study. To 
participate, providers must be at least 18 years of age and enrolled in a medical training 
program or currently working as a healthcare provider. Participants were recruited from 
the Indiana University School of Medicine by the use of email listservs and posted flyers. 
Recruitment materials indicated that the study was examining, “Clinical Decision-Making 
for Pain Management,” and was interested in gaining a better understanding of how 
healthcare trainees and providers make decisions for chronic pain patients. 
Participants 
 Participants who completed the online portion of the study indicated at the end 
of the study if they were interested in being contacted for future studies. Only those 
participants who answered positively were recruited to participate in the follow-up 
qualitative portion, which consisted of a one-on-one interview to discuss treatment 
decision-making for chronic pain patients.  
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2.2 
This study used a mixed methods design that consists of both an online 
quantitative study and individual qualitative interviews. This study received approval 
from the Indiana University Institutional Review Board (IRB #1102004842). Only those 
20 trainees who completed a follow-up interview were included in this analysis. This will 
allow for a more in-depth examination of participants’ clinical decision-making, 
awareness, and attitudes by examining specifically their qualitative and quantitative 
data. Both study portions took no more than one hour each to complete. Participants 
were compensated with a $75 Amazon.com gift card for each portion of the study they 
completed. 
Procedure 
 
2.2.1 Quantitative study 
The quantitative portion of the study was administered online. Participants 
contacted the study investigators through a study email to indicate their interest. 
Interested participants were screened for eligibility (e.g., over 18 years of age, 
healthcare trainee or provider); less than 5% of individuals who contacted study 
investigators did not meet eligibility requirements. Eligible participants were given a 
unique username and password and directed to the study webpage. The introduction 
page explained that the study purpose was to gain a better understanding of how 
providers and trainees make decisions about chronic pain management. After logging in, 
participants were asked to consent to the online portion of the study. Participants were 
then asked to provide demographic information. After reviewing the instructions page, 
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participants were asked to make treatment decisions for a series of clinical vignettes. 
Next, they completed a battery of self-report measures, including measures assessing 
attitudes toward women and Black individuals. Participants then reported the 
information they used when making decisions for the vignettes. Finally, they were asked 
to guess at the study purpose. Directions given to participants and a list of the measures 
used in the online study are included in Appendix A. 
 
2.2.1.1 
Participants for the online portion of the study were presented with a series of 
computer-simulated images of patients experiencing pain. The simulated patients were 
created using innovative FaceGen Modeller software (129). FaceGen is a novel tool that 
allows the creation of realistic facial stimuli based on the Facial Action Coding System 
(FACS; 130). FACS is an anatomically based facial expression coding system that uses 58 
Action Units related to facial expressions and emotions (130). For instance, the facial 
expression of pain consists of lowering brow, nose wrinkling/upper lip raising, tightening 
of the orbital muscles surrounding the eye, and eye closure (131-133). FaceGen 
software allows for the presentation and standardization of patient pain expressions 
across the manipulated variables of interest (e.g., sex and race), thus, increasing the 
experimental control and ecological validity of the stimuli (130). Similar virtual human 
Clinical vignettes 
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† The larger investigation examined the influence of patients’ mental status. Alternative 
text for depressed patient vignettes included, “The patient denies any other physical 
health symptoms. The patient does report symptoms of depression over the past 6 
months.” 
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(VH) technology has been used in previous studies on pain decision-making with 
participants rating the clinical vignettes as highly realistic and reflective of real clinical 
scenarios (30, 31).  
 Participants were presented with still images of 16 simulated patients who vary 
by sex and race variables. The images were accompanied by text-based information 
about patients’ medical status and history, which was standardized for all patients [see 
Figure 2.1]. For all patients, the text-based vignettes presented equivalent information 
regarding the patients’ vital signs (within normal limits) and history of chronic pain (e.g., 
pain began from a back injury one year prior). In addition, all patients were described as 
being open to all treatment types with no treatment contraindications. The patient 
vignettes were presented in random order. 
                     
Figure 2.1 Virtual human images and text vignette
Temperature: 98.7 BP: 113/70 Pulse: 71 Respiration: 21 Mental Status: A/O X 3 
The patient presents with lower back pain of approximately one year duration. The patient 
reports that the pain began after lifting a heavy box at home. The pain is located in the lower 
back and limits the patient’s ability to perform normal daily activities. The patient expresses 
an openness to any treatment recommendation and has no absolute contraindications for 
the treatments listed below (i.e., there are no medical reasons to avoid certain treatments). 
The patient denies any other physical or mental health symptoms.† 
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2.2.1.2 
Lens model methodology was used to provide a quantitative estimate of how 
influential patient sex and race were in each trainee’s clinical decision (92). Participants 
made pain treatment decisions using visual analogue scales (VASs). Participants used 
separate scales to rate their likelihood to consider/recommend a list of commonly 
prescribed treatments for chronic pain (see Treatment Decisions below). 
Lens model 
 
2.2.1.3 
 
Measures 
2.2.1.3.1 Demographic information 
Participants provided information regarding their age, sex, race/ethnicity, and 
current level of healthcare training. Participants rated on separate VASs their clinical 
and personal experience with chronic pain from 0 (“Not at all experienced”) to 100 
(“Very experienced”). 
 
2.2.1.3.2 Treatment decisions 
Participants in the larger study rated their likelihood to consider/recommend a 
list of 10 commonly used treatments for chronic pain: 1) opioid/narcotic pain 
medication; 2) non-opioid/non-narcotic medication; 3) antidepressant medication; 4) 
over-the-counter pain medication; 5) lifestyle activities, such as diet and/or exercise; 6) 
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physical therapy; 7) ice, heat, and/or analgesic cream; 8) referral to a mental health 
provider for counseling; 9) referral to a pain specialist; 10) no intervention at this time; 
return in 1 month. Participants provided their ratings on separate VASs anchored from 0 
(“Not at all likely”) to 100 (“Extremely likely”). Although this list does not exhaust the 
chronic pain treatments available to providers and patients, it does include common 
treatments recommended by clinical guidelines (134). 
Based on previous findings and current gaps in the literature, for the purposes of 
this study, only four treatments were analyzed: 1) opioid/narcotic pain medication; 2) 
antidepressant medication; 3) physical therapy; 4) referral to a pain specialist. The 
pharmacological treatments were chosen to help further understand previously 
identified sources of treatment disparities (i.e., opioid and antidepressant medication). 
The majority of the disparities research has focused on opioid medications for the 
treatment of pain; however, findings remain inconsistent (45, 70). While little is known 
about antidepressant treatment disparities in the context of pain, research on 
antidepressants has found women are prescribed antidepressant medication at twice 
the rate of males with depression (135), and Black depressed patients receive less 
antidepressant medications than White patients (82).  Furthermore, non-
pharmacological treatments, such as physical therapy and referral to a pain specialist, 
have been recommended in clinical guidelines for pain management (9); however, these 
treatment options have been under-researched. These treatments may be susceptible 
to patient demographic influences due to provider concerns about credibility of pain 
reports and perceived access to treatment.  
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2.2.1.3.3 Gender attitudes 
The Ambivalent Sexism Inventory (ASI) is a 22-item measure of gender attitudes. 
The ASI integrates positive and negative attitudes that can lead to gender stereotypes 
(136, 137). The Benevolent Sexism (BS) scale assesses “positive” attitudes toward 
women in traditional gender roles, such as protective paternalism, idealization of 
women, and desire for intimate relationships; an example item is, “Women, compared 
to men, tend to have a superior moral sensibility” (137). The ASI also includes a Hostile 
Sexism (HS) scale that assesses negative attitudes about women, such as dominative 
paternalism, derogatory beliefs, and heterosexual hostility. An example from this scale 
is the item, “Most women fail to appreciate fully all that men do for them” (137). 
Participants indicated their agreement with each statement on a 0 (disagree strongly) to 
5 (agree strongly) scale, with some items reverse scored.  Higher scores on the ASI 
indicate more negative attitudes in regards to women. For these analyses, total scores 
(e.g., mean of all items on the ASI), and subscale scores (e.g., means for BS and HS) were 
analyzed.  
Glick and Fiske (1996) previously assessed reliability and found the ASI to have 
good internal consistency (Cronbach’s alpha range from 0.73 to 0.92).  The BS and HS 
subscales have also been found to be reliable across samples (BS α =0.73-0.85; HS α 
=0.80-0.92; 136, 137). The ASI was also found to be uncorrelated with measures of self-
deception but weakly correlated with impression management (r= 0.13-0.31); however,  
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the authors found there were multiple weak relationships across the impression 
management scale and concluded the measure had minimal risk of social desirability 
bias (137). 
 
2.2.1.3.4 Racial attitudes 
The Complimentary Stereotypes and Negative Prejudice scale (CSNP) is a 30-item 
scale used to assess explicit racial biases toward Black individuals. Similar to the ASI, the 
CSNP integrates two types of racial attitudes, positive and hostile (138). The 
Complimentary Stereotypes (CS) scale measures positive stereotypes of Black people as 
athletic, rhythmic, musical, and socially and sexually competent. An example of a 
positive stereotype is the item, “A Black person is wasting an opportunity by not getting 
involved in athletics” (138). The CSNP also includes a scale of Negative Prejudice (NP) 
that assesses negative stereotypes of Black people’s inherent inferiority, their role in 
government policy and interracial contact. An example of a negative stereotype is, “The 
welfare system really just allows Black people to ‘mooch’ money from the government” 
(138). Although traditional measures of stereotype tend to focus solely on negative 
stereotypes, positive stereotypes are harmful as they often serve to legitimize 
discrimination and ignore individuality among Black individuals (138). Participants 
indicated their agreement with each statement on a 1 (strongly disagree) to 7 (strongly 
agree) scale with some items reverse scored. Higher scores on the CSNP indicate more 
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negative attitudes about Black individuals.  For these analyses, total scores (e.g., mean 
of all items on the CSNP), and subscale scores (e.g., means for CS and NP) were analyzed. 
Previous examinations support the reliability and internal consistency of the 
CSNP, with Cronbach’s alpha ranging from 0.82 to .90 (138).  The CS and NP subscales 
have been found to be reliable across different racial and ethnic groups (CS α =0.71-.89; 
NP α =0.80-.87; 138). Previous examinations have found convergent validity between 
the CS and NP, as the two subscales were consistently and positively correlated (r= 0.14-
0.34), indicating individuals who hold negative stereotypes also tend to hold 
complimentary stereotypes (138). The CSNP was also found to be not correlated with 
measures of impression management and self-deception, indicating minimal 
susceptibility to social desirability (138). 
 
2.2.1.3.5 Information used 
Participants indicated which information they used when making treatment 
decisions for the simulated patients. Participants choose from a list of items that 
included items such as patient vital signs, pain history, facial expression of pain, and 
patient demographics. They rated each item using a VAS from 0 (“Minimal influence”) to 
100 (“Maximal influence”). Item selection of “patient demographics” was used to 
examine trainees’ awareness. 
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2.2.1.3.6 Guess at study purpose 
Because study transparency and social desirability is a concern with vignette-
based studies, as well as those examining explicit attitudes, participants were asked to 
guess at the purpose(s) and/or hypothesis(es) of the study. Responses to this open-
ended question were examined in order to understand any influence participants’ 
awareness of the study purpose may have had on their responses.  
 
2.2.2 Qualitative study 
Twenty participants, who indicated their willingness to be contacted for future 
studies on the online portion of the study, were recruited for follow-up semi-structured 
interviews to discuss their reasons and motivations for choosing chronic pain 
treatments in clinical settings. These interviews will provide a fuller picture of the 
influence of patient sex and race on chronic pain decisions, as well as other patient- and 
provider-related factors that may influence their decisions.  
The interview guide was created after a series of meetings between the inter-
disciplinary research team. This team consisted of two physician-researchers, a health 
psychologist, and a communication researcher with expertise in chronic pain 
management and patient-provider communication. The interviewer was a clinical 
psychology graduate student with qualitative research experience. To enhance the 
reliability of the data collection, the same interviewer conducted all 20 interviews. Each 
interview took place in either the laboratory space located on Indiana University-Purdue 
University Indianapolis campus or in a private room at the Indiana University School of 
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Medicine’s library. The interviews were approximately 1 hour in duration and each 
participant was compensated with a $75 Amazon.com gift card.   
 The interview guide was based, in part, on the guide used in a previous 
qualitative study on physician decision-making for pain (24). The interview guide 
consisted of open-ended questions and probing questions to explore participants’ 
perspectives and opinions on pain treatments. Questions were designed to elicit 
conversation regarding trainees’ reasons and motivations for using particular pain 
treatments with particular patients they have worked with in clinical settings, including 
discussion of why they favor/disfavor particular treatment options.  In order to ensure 
that participants discuss a wide-range of treatment options, they were asked during the 
course of the interview to review a list of treatment options that mirror the same 
treatment types from the online study. The interviews also included questions 
pertaining to how decisions might vary depending on patient factors, such as sex and 
race, which are particularly relevant to this study, as well as other factors such as age 
and SES.  
The interview guide was piloted internally by the interviewer. Practice interviews 
were conducted with clinical psychology graduate students to finalize the specific 
wording, phrasing, and sequence of the questions prior to conducting the interviews 
with study participants. The interview guide is presented in Appendix B. 
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2.3 
Differences in demographic characteristics (e.g., age, sex, race) between the 20 
trainees and the larger sample of 100 participants were examined using independent t-
tests and chi-square analyses. 
Statistical analyses 
 
2.3.1 Influence of patient sex and race on trainees’ decisions 
The statistical data software SPSS was used for all quantitative analyses.  
 
2.3.1.1 
To test the hypothesis that a subset of healthcare trainees will be influenced by 
patient sex or race in their treatment decisions, individual multiple regression analyses 
were used to examine each participant’s decision. VH sex and race cues served as the 
independent variables and were entered simultaneously in the regression models. 
Treatment (opioids, antidepressants, physical therapy, referral to pain specialist) ratings 
were the dependent variables in each model. A linear equation was produced that 
optimally weights each sex and race cue in terms of its predictive contribution to the 
decision. The standardized regression coefficient (β) in each regression model 
represents the weight of each cue in each decision. This weight represents the unique 
contribution and importance of each cue in the individual participant’s clinical decision. 
A significant β indicates that a sex or race cue was reliably used in a particular treatment 
decision. The coefficient of multiple determination (R2) represents the amount of 
Idiographic analyses 
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variance in pain assessment and treatment ratings accounted for by the sex and race 
cues. A significant R2 indicates the sex and race cues (independently or collectively) were 
sufficiently weighted to result in a reliable decision equation. In other words, R2 is an 
index of how “relevant” the cues were to participants’ decisions. Consistent with 
previous studies investigating patients’ sex and race (31), β and R2 values will be 
examined at both the .05 and .10 alpha level.  
 
2.3.1.2 
Traditional group-based analyses were used to further examine my first 
hypothesis. Following idiographic analyses for all participants, descriptive statistics were 
used to determine: 1) the number of participants who were significantly influenced by 
patient sex and/or race (p < .10) for each treatment type, 2) the amount of variance 
accounted for by patient sex and race in trainees’ decisions; the semi-partial 
correlations values for each patient variable within each treatment decision were 
squared, and descriptive statistics were used to summarize these values, 3) the average 
R2 for each treatment decision (i.e., the average amount of variance in treatment ratings 
that were accounted for by both patient cues), and 4) the variability in trainees’ “use” of 
the patient demographic cues (i.e., compare the number of trainees who gave higher 
ratings to male/female patients and White/Black patients).  
Nomothetic analyses 
Nomothetic statistical analyses were used to examine the hypothesis that female 
and Black patients will receive different treatment ratings (e.g., lower treatment ratings, 
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except in the case of antidepressants for female patients) than male and White patients, 
respectively. After computing average treatment ratings for the sample, paired samples 
t-tests were used to compare the average ratings between male/female vignettes and 
Black/White vignettes. These analyses were used to examine sex and race differences 
regarding the four treatment recommendations in the overall sample. Effect sizes were 
calculated for significant results using the equivalent of Cohen’s d for dependent     
cases (dz). 
 
2.3.1.2.1 Trainees’ level of self-awareness 
In order to examine my second hypothesis regarding trainees’ awareness of the 
influence of patient sex and race on their pain management decisions, I compared the 
number of trainees that actually used sex and race in their treatment decisions (as 
determined by significant β values for each treatment decision [see idiographic analysis]) 
to the number of trainees who reported using sex and race cues in their treatment 
decisions (as determined by their responses to the “Information Used” questionnaire). 
Actual and reported use were analyzed as dichotomous variables.  
Trainees’ actual and reported use of patient demographics were examined by 
both frequency and concordance analyses. Specifically, the percentage of the sample 
that endorsed or denied using demographics and the percentage that significantly used 
or did not use patient demographics in their treatment decisions are reported. 
Concordance (e.g., those who endorsed and actually used [positive agreement], and 
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those who did not endorse and did not use [negative agreement]) and discordant (e.g., 
those who endorsed and did not use, and those who did not endorse and did use) 
indices are reported. McNemar’s test was used to examine participants’ awareness. This 
test indicates whether the level of disagreement between participants’ actual and 
reported use is statistically significant (p< .05).  
 
2.3.1.2.2 Trainees’ racial and gender attitudes 
For my third hypothesis, I expect gender- and racial-attitudes will be associated 
with providers’ treatment ratings. Pearson’s correlations were calculated to examine 
the linear relationship between both the 1) total ASI and CSNP attitude scores and 2) 
separate subscale scores for each attitude measure and treatment decisions (e.g., ASI 
total score, Benevolent Sexism score, and Hostile Sexism score will be correlated 
separately with female opioid ratings).  Separate correlations were calculated for male 
vs. female patients and White vs. Black patients. Fisher r-to-z transformation analyses 
were used to test for differences in the magnitude of these relationships. For example, 
participants’ ASI total scores were correlated with their opioid treatment ratings for 
both male and female patients, and the Fisher r-to-z analyses were used to examine 
significant differences in the magnitude of these two correlation coefficients.   
Should attitudes account for a significant portion of variance in trainees’ 
treatment decisions, attitudes will be tested as potential mediators/confounders. To 
quantify the effect of attitudes as potential mediators/confounders of the relationship 
46 
 
between patient demographic characters and trainees’ treatment decisions, hierarchical 
regression models will be constructed. VH sex or race is included in Step 1 of separate 
models, with gender and racial attitudes (separate analyses for total and subscale 
attitude scores) added at Step 2, respectively. Treatment ratings are the DVs in 
respective models. The change in effect size is computed as (BVHsex/race step1  – B VHsex/race 
step2)/ B VHsex/race step1 × 100. Sobel’s tests are conducted to examine whether the 
mediator/confounder partially accounted for any of the observed changes within the 
models. 
 
2.3.1.2.3 Qualitative interviews 
 All interviews were transcribed verbatim from audio recordings by a HIPAA-
certified transcription office. The interviewer checked all transcripts for accuracy and 
removed any identifying information.  
Interview data analysis included the inter-disciplinary research team. During the 
first phase of data analysis, each member of the team read each transcript 
independently for overall impressions and discussed noticeable patterns or salient 
statements during biweekly meetings. After these initial discussions, the team 
continued to read the interviews independently and regularly met to discuss the 
interviews and develop a preliminary list of themes reflected in the data. This iterative 
process continued until no new themes had been identified and saturation had occurred. 
Based on similar qualitative chronic pain research, the interdisciplinary team worked to 
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ensure that codes were grounded in the data by meeting the criteria of recurrence and 
repetition in order to ensure codes are not influenced by individual notions or bias (24). 
Once a preliminary codes list had been created, the team continued to review 
transcripts and discuss any codes that could be collapsed into overarching categories, 
eliminate codes due to lack of support from the data, and discuss any discrepancies. 
Once a consensus had been reached, a final code list was formulated.  
 Next, the interviewer used the final code list to code the previously reviewed 
transcripts independently. The team again met regularly on every fourth transcript to 
ensure inter-rater reliability and to refine the final code list as needed. Once all of the 
transcripts had been properly coded, the interdisciplinary team searched for patterns 
and variations among responses to ascertain whether some trainees had generally more 
positive or negative experiences and attitudes toward treating chronic pain and specific 
chronic pain patient populations.  
All of the transcripts were coded and analyzed using Atlas-ti (Atlas-ti Scientific 
Software Development GmbH, Berlin, Germany). 
 
2.4 
The current study was powered for the idiographic analyses of the lens model 
approach. In order to ensure the model’s parameters were sensitive enough to detect 
judgment differences, this study employed a profile-to-cue ratio of 8:1 (16 vignettes  
 
 
Power analysis 
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with 2 cues of interest), which exceeds the recommended ratio of 5:1 and increases the 
power of the study (94). In addition, each possible cue combination was presented four 
times to further enhance statistical power.  
An a priori power analysis was conducted for the nomothetic analyses using 
G*Power (139). To calculate power, effect sizes were estimated from a study that used 
similar research methodology and participants, and also examined sex and race 
differences in pain treatment decisions (see 32). In that study, effect sizes for patient 
sex and race ranged from 0.59 to 0.70. The current power analysis was based on a two-
tailed dependent samples t-test, ∝ = 0.05, and power = 0.80 to determine the sample 
sizes needed to detect significant differences at the nomothetic level of analysis. The 
power analysis estimated this study would need a sample size ranging from 19 to 25 
participants (based on an effect size of 0.70 and 0.59, respectively); 21 participants are 
needed based on the average of these effect sizes (effect size = [0.59+0.70]/2 = 0.65). 
This study recruited 20 participants, which falls in the range suggested by the power 
analysis. I contend this study is sufficiently powered (for nomothetic analyses examining 
sex and race influences on treatment decisions) with 20 participants. Lens model studies 
with an adequate profile-to-cue ratio have increased power at the group-level of 
analysis due to greater reliability of each participant’s responses through the use of 
multiple observations (94). Moreover, each patient cue combination was presented four 
times to further enhance statistical power. Finally, the mixed methods approach used in 
this study will enhance its overall quality and statistical power (125). 
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CHAPTER 3. RESULTS 
 
3.1 
The final sample consisted of 20 trainees (Table 3.1). The majority of trainees 
were female (65%). Most trainees reported their race as Caucasian (65%) or Asian 
American (20%). Average age of the sample was approximately 27 years old (SD= 3.03). 
All trainees were currently enrolled in an academic program at the Indiana University 
School of Medicine, with 10 trainees currently enrolled in medical school and the other 
half in residency training. Trainees’ indicated an average of 29.5 (SD = 26.8) clinical 
experience and an average of 27.2 (SD = 23.3) personal experience with chronic pain.  
Although a validated interpretation rubric for this measure is not available, I interpret 
these data to indicate that trainees’ average clinical and personal experience was small-
to–medium. 
 
Sample characteristics 
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Table 3.1 Demographic characteristics 
  n % total 
Training Experience 
 Medical student 10 50% 
 Medical resident 10 50% 
Sex 
 Female 13 65% 
 Male 7 35% 
Race/ethnicity 
 Caucasian 13 65% 
 Asian 4 20% 
 African-American 1 5% 
 Hispanic 1 5% 
 Middle-eastern 1 5% 
 
As this was a secondary analysis, the 20 trainees were compared to the larger 
sample participants (n=100) to examine any group differences. No significant differences 
emerged between the age [t(98)=1.04, p=.302], sex [χ2(1)=1.96, p=.16], race [χ2(3)=.438, 
p=.93], or ethnicity [χ2(1)=.344, p=.558] of the two samples.  
 
3.2 
Descriptive information on trainees’ attitude scores, experience ratings, and 
treatment decision ratings are presented in Table 3.2. Pearson’s correlations were 
calculated to examine discriminant validity across measures (Table 3.3). As found in a 
previous investigation, the ASI and CSNP scales were positively correlated (138). 
Furthermore, the ASI’s Hostile Sexism scale was negatively correlated with trainees’ 
personal experience with chronic pain (r=-.45, p<.05), and the CSNP’s Complementary 
Measurement information 
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Stereotypes scale was positively correlated with trainees’ opioid ratings (r=.45, p<.05). 
The theoretical significance of these correlations is questionable, suggesting that these 
results are likely spurious or due to unmeasured variables. 
 
Table 3.2 Descriptive information for measures 
Measures  Mean (SD) Range  
Ambivalent Sexism Inventory 1.9 (.84) 0.5 – 3.5 
 Benevolent Sexism 2.2 (.86) 0.5 - .3.8 
 Hostile Sexism 1.7 (.74) 0.3 – 3.5 
Complementary Stereotypes Negative Prejudice 3.1 (.74) 1.9 – 4.3 
 Complementary Stereotypes  3.7 (.94) 2.2 – 5.5 
 Negative Prejudice 2.6 (.83) 1.2 – 4.2 
Trainees’ experience with chronic pain   
 Clinical experience 29.5 (26.8) 0.0 – 74 
 Personal experience 27.2 (23.3) 0.0 – 75 
Treatment ratings   
 Opioid ratings 18.2 (20.1) 0.0 – 62.0 
 Antidepressant ratings 38.7 (14.2) 0.5 – 62.6 
 Physical therapy ratings 74.7 (28.5) 0.0 – 100 
 Refer to pain specialist ratings 11.9 (14.4) 0.0 – 51.6 
ASI ratings from 0-5 (higher sexist attitudes) 
CSNP ratings from 1-7 (higher racist attitudes) 
Experience ratings on 0-100 (“Very experienced”) VAS 
Treatment ratings on 0-100 (“Extremely likely”) VAS 
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Table 3.3 Discriminate validity between measures 
 
 ASI  
BS 
 
HS 
CSNP  
CS 
 
NP 
Clinical 
experience 
Personal 
experience 
Opioids Antidep. PT Refer to 
PS 
ASI total score 1 .89± .92± .78± .57* .74± .27 -.40 .14 -.13 -.10 .26 
 BS subscale  1 .65* .67* .51* .61* .26 -.28 -.01 -.09 -.01 .20 
 HS subscale   1 .75± .53* .73± .24 -.45* .25 -.14 -.16 .27 
CSNP total score    1 .86† .82± .13 -.34 .32 .10 -.12 .16 
 CS subscale     1 .41 -.09 -.28 .45* -.03 -.18 .08 
 NP subscale      1 .33 -.29 .06 .21 .01 .21 
Clinical experience       1 -.12 -.11 -.19 .34 -.26 
Personal 
experience 
       1 -.40 .04 -.06 -.02 
Opioid ratings         1 .21 -.08 .42 
Antidepressants          1 .01 .36 
PT ratings           1 -.02 
Refer to PS ratings            1 
± p<.001; * p<.05 
Cells represent Pearson’s correlation coefficients 
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3.3 
Individual regression equations were computed for each participant to model 
his/her decision-making influences across 4 chronic pain treatments (opioid, 
antidepressant, physical therapy, referral to a pain specialist). Each regression model 
consisted of 2 independent variables (VH sex and race) that were entered 
simultaneously. Each trainee’s VH sex and race beta value and their combined R2 value 
is presented in Table 3.4. 
Study hypothesis 1: Influence of patient demographics 
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Table 3.4 β and R2 values for each cue across decision 
User Opioids Antidepressants Physical Therapy Referral to pain 
specialist 
 Sex Race R2 Sex Race R2 Sex Race R2 Sex Race R2 
1 -.17 .29 .11 -.18 -.03 .03 <.01 <.01 <.01 -.11 .17 .04 
2 <.01 <.01 <.01 .01 -.02 <.01 -.05 -.41 .17 -.24 .28 .14 
3 -.51* .21 .31† -.46† -0.29 .29 .16 .05 .03 -.09 .13 .03 
4 -.08 .39 .16 -.07 -.03 .01 <.01 <.01 <.01 -.26 .26 .13 
5 -.47† .21 .26 .14 -.15 .04 <.01 <.01 <.01 -.28 .05 .08 
6 .23 -.41 .22 .34 -.16 .14 -.25 -.20 .10 <.01 <.01 <.01 
7 .23 .30 .15 .03 .05 .01 .26 .26 .13 .40 .34 .27 
8 .05 .40 .16 -.03 -.03 .01 -.18 .29 .12 .40 -.01 .16 
9 .06 -.25 .07 .08 .09 .02 .22 .44† .24 -.11 -.05 .02 
10 .32 .02 .10 -.40 -.40 .32† .45† -.08 .21 -.12 .21 .06 
11 -.25 -.25 .13 -.01 -.26 .07 .05 .24 .06 .14 .14 .04 
12 -.23 -.15 .07 .16 .06 .03 .28 -.34 .19 .55* .04 .31† 
13 <.01 .02 .01 -.01 -.01 <.01 -.54* .15 .31† <.01 <.01 <.01 
14 .48† -.16 .26 -.07 -.17 .04 .08 .10 .02 -.08 -.21 .05 
15 .07 -.07 .01 .21 -.31 .14 <.01 .45† .20 .26 -.26 .13 
16 .09 .37 .14 -.17 -.11 .04 -.21 -.02 .04 <.01 <.01 <.01 
17 .16 -.23 .08 .08 -.08 .01 <.01 <.01 <.01 .11 .44 .21 
18 .12 -.02 .02 -.10 -.12 .03 -.11 -.11 .03 .15 <.01 .02 
19 -.26 .24 .12 -.08 .03 .01 -.26 -.50† .31† -.21 -.16 .07 
20 -.48† .16 .26 .13 .02 .02 -.18 -.36 .16 -.02 .22 .05 
† p<.10, * p<.05 
Note: Sex and Race values represent beta weights (β). R2 values represent the amount of variance accounted for 
by both Sex and Race 
+β in Sex or Race column, trainee gave higher treatment ratings to male or White patients  
-β in Sex or Race column, trainee gave higher treatment ratings to female or Black patients 54 
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3.3.1 Idiographic analyses 
Significant results of the idiographic analyses are presented in Table 3.5 and 
discussed below. 
 
Table 3.5 Idiographic analyses 
Cue  Treatment Decision 
  Opioid Antidepressant Physical Therapy 
Referral to a Pain 
Specialist Total 
Sex Male 3 1 1 0 5 
 Female 1 0 1 1 3 
Race White 0 0 1 0 1 
 Black 0 0 2 0 2 
Columns represent the treatment decision. Rows represent the individual cue level. Cell 
values represent the number of participants with a significant policy for a particular 
treatment decision (column), weighted toward a particular individual cue (row). For 
example, under the Opioid column, in the Sex row, there is three for Male and one for 
Female. This indicates that four total participants used VH sex as a consistent cue (p<.10) 
when recommending opioid treatments. Specifically, three trainees gave higher opioid 
ratings to male VH, and one trainee gave higher opioid ratings to female VH.  
 
3.3.1.1 
Results indicated that 4 trainees (20% of all participants) had a statistically 
reliable cue use when recommending opioid treatment. One trainee had a statistically 
significant (p<.05) cue use for patient sex, and 3 trainees had a cue use for patient sex 
that approached significance (p<.10). Of these four trainees, three trainees gave higher 
opioid recommendations to male patients than to female patients, and one trainee gave  
Opioid recommendations 
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higher opioid recommendations to female patients. Race was not a statistically reliable 
cue (at p<.05 or p<.10) for any of the 20 trainees when making opioid treatment 
decisions.  
 
3.3.1.2 
One trainee (5% of all participants) had a statistically reliable cue use when 
recommending antidepressant treatment (p<.10). This trainee gave higher 
antidepressant treatment ratings for male patients compared to female patients. Race 
was not a statistically reliable cue for any of the participants when making 
antidepressant treatment decisions.  
Antidepressant recommendations 
 
3.3.1.3 
Five trainees were influenced by patient demographics for physical therapy (PT) 
recommendations (25% of all participants). Patient sex was consistently used by 2 of 
these trainees. One gave higher ratings to female patients (p<.10), and one gave higher 
PT ratings to male patients (p<.05). Three trainees reliably used patient race (p<.10). 
Two gave higher PT ratings to Black than White patients, with the other trainee giving 
higher PT ratings to White than Black patients.   
Physical therapy recommendations 
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3.3.1.4 
One trainee (5% of all participants) had a statistically significant cue use when 
recommending referral to a pain specialist (p<.05). This trainee gave higher pain 
specialist ratings to female patients than for male patients. Race was not a statistically 
reliable cue for any of the trainees. 
Referral to a pain specialist recommendations 
 
3.3.1.5 
Examination of R2 values across trainees found both patient sex and race 
accounted for as much as 31% (mean = 13%) of the variance in trainees’ ratings to treat 
with an opioid and as much as 32% (mean = 6%) in their decision ratings to treat with an 
antidepressant. Additionally, patient demographics accounted for as much as 31% 
(mean = 12%) of the variance in trainees’ PT ratings, and 31% (mean = 9%) in their 
ratings to refer to a pain specialist.   
Variance accounted for by patient sex and race 
To quantify the amount of variance accounted for by patient sex and race, 
separately, semi-partial correlations were examined for each treatment decision (Table 
3.6). The following values represent the maximum amount and average amount of 
variance (in parentheses) accounted for by each sex and race cue. Results of these 
calculations indicated that patient sex accounted for as much as 27% (7%) and race 
accounted for as much as 18% (6%) of the variance in trainees’ opioid ratings, 
respectively. Patient sex and race accounted for as much as 21% (3%) and 16% (3%), 
respectively, of the variance in trainees’ ratings to treat with an antidepressant. Patient 
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sex and race accounted for as much as 29% (5%) and 26% (7%), respectively, in trainees’ 
ratings to recommend PT, and 31% (5%) and 19% (4%) in their ratings to refer to a pain 
specialist. Further descriptive data is presented in Table 3.6. 
 
Table 3.6 Cue variance within decision 
Treatment Decision Sex Race R2 
 Mean (SD) 
Range 
Mean (SD) 
Range 
Mean (SD) 
Range 
Opioid .07 (.09) .06 (.05) 0.13 (.09) 
 <.01-.27 <.01-.18 <.01-.31 
Antidepressant .03 (.06) .03 (.04) .06 (.09) 
 <.01-.21 <.01-.16 <.01-.32 
Physical Therapy .05 (.07) .07 (.08) .12 (.10) 
 <.01-.29 <.01-.26 <.01-.31 
Referral to a Pain Specialist .05 (.07) .04 (.05) .09 (.09) 
 <.01-.31 <.01-.19 . <.01-.31 
Note: Sex and Race values represent squared semi-partial correlations. R2 
values represent the amount of variance accounted for by both Sex and 
Race. 
 
3.3.2 Nomothetic analyses 
Nomothetic results indicated that 10 trainees had a consistent cue use (p<.10) 
across treatment decisions. Thus, 50% of trainees sampled used patient sex or race in a 
statistically consistent manner when making pain treatment decisions. Seven of these 
10 trainees (35% of all participants) had at least 1 significant patient sex cue coefficient 
(standardized beta), and 3 trainees (15% of all participants) had at least 1 significant 
patient race cue coefficient. No trainees were consistently influenced by patient sex and  
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race within or across treatment decisions, and only one trainee was reliably influenced 
by patient sex across more than one treatment (e.g., use of patient sex for both opioid 
and antidepressant decisions).  
For each trainee, average treatment ratings were calculated across patient sex 
and race. Normality assumptions were violated or almost violated for the majority of 
treatment ratings. Thus, paired samples t-tests and Wilcoxon signed-rank tests were run 
for all analyses. Results were the same for both sets of analyses; for ease of 
interpretation, t-test findings are reported in Table 3.7.  
Table 3.7 Nomothetic analyses 
Decision Cue  Mean (SD) t dz 
Opioid Sex Male 17.73 (20.9) ns <.01 
  Female 17.72 (20.4)   
 Race White 17.13 (19.5) ns .28 
  Black 18.31 (21.5)   
Antidepressant Sex Male 36.74 (16.8) ns .05 
  Female 37.12 (17.1)   
 Race White 38.64 (17.2) 2.159* .48 
  Black 35.22 (16.7)   
Physical Therapy Sex Male 75.61 (29.0) ns .09 
  Female 76.07 (29.1)   
 Race White 76.64 (29.7) ns .16 
  Black 75.67 (28.5)   
Refer to Pain Specialist Sex Male 11.78 (15.3) ns .20 
  Female 11.19 (13.9)   
 Race White 10.98 (15.1) ns .25 
  Black 12.00 (14.3)   
* p<0.05 
t used for paired samples t-tests 
dz, Cohen’s d used as effect size indices for paired samples t-tests 
ns, not significant  
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Paired-samples t-tests found that average ratings for opioid, antidepressant, and 
physical therapy did not differ significantly between male and female patients.  
Although referral to a pain specialist ratings did not reach statistical significance, there 
was a small effect of males receiving higher referral ratings than female patients 
[t(19)=.888, p=.38, dz=.20]. Average antidepressant ratings were significantly different 
between White and Black patients. Specifically, on average, trainees gave higher 
antidepressant ratings to White than Black patients [t(19)=2.159, p<0.05, dz=.48]. Two 
other treatment options did not reach statistical significance; however, small effects 
were detected. Specifically, there was a small effect of Black patients receiving higher 
opioid ratings than White patients [t(19)=-1.231, p=.23, dz=.28], and Black patients 
received higher referral to a pain specialist ratings than White patients [t(19)=-1.140, 
p=.27, dz=.25].  
Exploratory independent samples t-tests were used to compare treatment 
ratings between male and female trainees, as well as between White and non-White 
trainees. These analyses found no significant differences between male (n=7) and 
female (n=13) trainees’ ratings for opioids, physical therapy, or referral to a pain 
specialist; however, there was a non-significant trend for female trainees to give higher 
antidepressant ratings than male trainees [t(18)=-2.077, p=.052, dz=.85]. Similarly, there 
were few differences between White (n=13) and non-White (n=7) trainees, except non-
White trainees gave higher physical therapy ratings than White trainees [t(18)=-1.764, 
p<.05, dz=.74]. Given the small sample size, these findings should be interpreted with 
caution. 
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To examine whether social desirability responses were influencing trainees’ 
treatment decision ratings, paired-samples t-tests were used to compare treatment 
ratings for trainees who guessed correctly at the study’s purpose (n=15) and ratings for 
trainees who guessed incorrectly (n=5) at the end of the online study. No significant 
treatment rating differences occurred between these two groups (p=ns), suggesting that 
awareness of the study’s purpose did not influence trainees to make different ratings.  
 
3.4 
At study conclusion, participants were asked to indicate the information they 
used to make treatment ratings for the patients. From a provided list, participants 
indicated each factor that influenced their decisions and rated the amount of influence 
for each selected item on a VAS scale. Participants’ responses to the item, “Patients’ 
demographic characteristics (e.g., sex, race, age)” were used to evaluate the extent to 
which trainees demonstrated consistency in the cues they reported using versus the 
cues they actually used in their decision-making process.  
Study hypothesis 2: Trainee awareness of decision-making influences 
Examination of trainee’s responses indicated that 13 out of 20 trainees (65% of 
all participants) reported using patient demographics when making treatment decisions 
for the chronic pain vignettes.  This finding is in contrast to the idiographic regression 
analyses, which indicated that 35% and 15% of all trainees used patient sex and race, 
respectively, in a statistically reliable manner. Thus, while 13 trainees reported using 
patient demographics, only 10 trainees were actually influenced by either patient sex or 
race.  
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Crosstabulation was used to further examine concordance between trainees’ 
reported use of patient demographics (0= Did not report being influence; 1= Reported 
being influenced) and their actual use of patient sex and race as indicated by the results 
of idiographic regression analyses (0 = Not statistically influenced; 1= Influenced by 
patient sex or race [p<0.10]).   
Of those 13 trainees who reported using demographics, 6 were not statistically 
influenced by patient sex or race in their treatment decisions; the remaining 7 trainees 
reported being influenced and were actually influenced by patient demographics in their 
treatment decisions. Alternatively, of those 7 trainees who did not report using patient 
demographics in their treatment decisions, 4 were not statistically influenced by either 
patient sex or race; the remaining 3 trainees were influenced by patient demographics. 
Thus, 11 (55%) trainees demonstrated concordance (which suggests awareness of their 
decision-making processes), and 9 (45%) trainees demonstrated discordance (which 
suggests unawareness) between the reported and actual influence that patient 
demographics had on their chronic pain treatment decisions. Additionally, of the 11 
concordant (“aware”) trainees, 7 demonstrated awareness of being influenced by 
patient demographics, and 4 trainees demonstrated awareness of not being reliably 
influenced by patient demographics in their treatment decisions. Of the 9 discordant 
(“unaware”) trainees, 3 trainees demonstrated unawareness that they were reliably 
influenced by patient demographics in their treatment decisions, and 6 trainees 
reported using patient demographics but did not reliably use these patient factors in 
their treatment decisions. 
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McNemar test revealed that the sample did not demonstrate statistically 
significant discordance between their reported and actual use of patient demographics 
(p = .51). Based on my operational definition of awareness (i.e., concordance between 
reported and actual use of patient demographics), the sample generally demonstrated 
awareness of their decision-making processes for chronic pain treatment decisions. 
In order to further examine trainees’ level of awareness, sex and race beta 
weights were re-evaluated using a more liberal p<.20 to indicate  whether trainees were 
significantly influenced by patient demographics. This more liberal alpha-level resulted 
in one trainee being re-categorized as “aware” of using patient demographics, which 
resulted in 12 concordant and 8 discordant trainees. A follow-up McNemar test yielded 
similar results to the previous analysis, in that the sample did not demonstrate 
significant discordance between their reported and actual use of patient demographics 
(p=.29).  
 
3.5 
Attitude scores for each participant were calculated based on the mean of the 
overall attitude measures as well as scores for each measure’s subscale (e.g., positive or 
negative attitudes). Four participants had one missing item from either the racial or 
gender attitude measure. Missing item responses were imputed with the mean of the 
missing subscale’s score (140). Both the ASI and CSNP were found to have good internal 
Study hypothesis 3: Treatment decision relationship to attitudes 
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consistency in this sample (ASI Cronbach’s alpha = .90, CSNP Cronbach’s alpha =.86). 
Descriptive information of trainees’ attitude scores is presented in Table 3.2. 
Pearson correlations were used to examine the relationship between 
participants’ gender and racial attitudes (total and sub-scale scores) and each treatment 
decision rating for male, female, White, and Black patients (Table 3.8). Opioid ratings for 
White patients were positively correlated with scores on the complimentary stereotypes 
subscale of the CSNP (r =.48, p<.05); thus, endorsement of more “positive” stereotypes 
about Black individuals were related to higher opioid ratings for White patients.  No 
other significant correlations were found between attitude scores and treatment 
recommendations. Fisher r-to-z transformation analyses were used to examine 
differences in the correlations between treatment ratings (for different patient 
demographic groups) and attitude scores; for instance, I examined differences in the 
correlation coefficients between male and female opioid ratings and gender attitude 
scores (total and sub-scales). These analyses found no significant differences between 
correlation coefficients, indicating that gender and racial attitudes are not more strongly 
associated with female and Black treatment recommendations than male and White 
recommendations, respectively, as hypothesized. 
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Table 3.8 Gender and racial attitude correlations 
 
Treatment Decision 
 
Attitude Scale 
Patient Sex Patient Race 
Male Female White Black 
Opioid Total score .139  .180  .357  .315  
 Positive scale -.012  .031  .482*  .421  
 Negative scale .243  .277  .094  .088  
Antidepressant Total score -.116  -.092  .004  .261  
 Positive scale -.244  -.147  -.125  .165  
 Negative scale .014  -.029  .148  .282 
Physical Therapy Total score -.06  .005  -.006  -.103  
 Positive scale .094  .135  -.083  -.177  
 Negative scale -.185  -.110  .088  .021  
Refer to PS Total score .287  .252  .171  .211  
 Positive scale .171  .135  .102  .119  
 Negative scale .338  .308  .192  .245  
*p<.05 
Values represent Pearson’s correlation coefficients 
For gender attitudes, correlations were run between treatment ratings for male and 
female patients, and the ASI total score, BS (positive) scale, and HS (negative) scale 
For racial attitudes, correlations were run between treatment ratings for White and 
Black patients, and the CSNP total score, CS (positive) scale, and NP (negative) scale 
 
For exploratory analyses, gender and racial attitudes were tested as potential 
mediators/confounders of the relationship between patient demographics and 
treatment decisions. Hierarchical regression analyses were used to determine change in 
influence of either patient sex or race (percent change in unstandardized B) when scores 
on the gender/racial attitude subscales were present in the model. However, patient sex 
and race accounted for such a small amount of the variance in providers’ treatment 
decisions (maximum B for sex, 12.76 p=.433, and race, 7.78 p=.123), that further 
analysis of the role of gender and racial attitudes was not indicated.  
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Further exploratory analyses examined any differences in attitudes based on 
trainees’ reported demographic information. Independent samples t-tests found male 
and female trainees endorsed similar gender and racial attitudes, and White and non-
White trainees endorsed similar gender attitudes. However, non-White trainees 
reported more negative racial attitudes overall [t(18)=-2.148, p<.05, dz=.97]  and more 
hostile racial prejudice specifically [t(18)=-2.679, p<.05, dz=1.3]. Given the small sample 
size and the heterogeneous group of non-White participants (see Table 3.1), replication 
is needed before drawing strong conclusions from these findings.  
 
3.6 
All 20 trainees who participated in the quantitative portion of the study 
participated in qualitative interviews. Of those contacted, I had a response rate of 52%. 
Twenty-two providers were asked to participate in an interview, but did not respond to 
the invitation. Independent samples t-tests revealed no significant difference in 
treatment ratings, clinical experience with pain, or gender/racial attitude scores 
between providers who did not respond to the invitation (n=22) and providers who 
participated in follow-up interviews (n=24, including the 20 trainees used in this 
investigation). However, providers who did not respond to the invitation had more 
personal experience with chronic pain than providers who were interviewed 
[t(44)=2.176, p<.05, dz=.59].   
Qualitative results 
Trainees were interviewed between 2 and 8 weeks after completion of the 
online portion of the study. Across all interviews, trainees spoke extensively about the 
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need to consider patients’ previous pain histories to determine treatment, such as the 
type/cause of pain and the severity/intensity of the patients’ reported pain. Additionally, 
trainees spoke about their comfort-level with common chronic pain treatments, 
including their hesitancy to prescribe certain treatments. The majority of this discussion 
centered on their discomfort and hesitancy to use opioid medications for chronic pain. 
The frequency of discussed themes is presented in Table 3.9. 
 
Table 3.9 Qualitative themes 
Theme Aware Unaware 
Most common themes   
Patients’ pain history 100% 100% 
Provider comfort level with treatments 100% 100% 
Themes surrounding patient sex   
Tailoring/individualizing treatments 100% 100% 
Patient presentation and description of pain 78% 82% 
Themes surrounding patient race   
Patient presentation and description of pain 78% 100% 
Beliefs about cultural differences 44% 56% 
 
 To better understand the influence of providers’ level of awareness of their 
treatment decision-making, interviews were examined between trainees who were 
statistically concordant between actual and reported use of demographics (Aware) and 
those who were discordant between their actual and reported use (Unaware). 
 Two methods were used to examine whether themes varied between aware 
and unaware trainees. In the first method, the interviewer reviewed trainees’ discussion 
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of the influence of patient sex and race and attempted to classify the trainee as either 
“aware” or “unaware” based solely on their discussion. These blind ratings were then 
compared to the statistical assignments. This method proved to be unreliable in 
determining whether “aware” and “unaware” trainees discussed different themes based 
on patient sex and race.  
 The second method used the statistical assignments of trainees’ level of 
awareness, and examined prominent themes regarding the influence of patients’ 
demographic characteristics between the two groups.  
 
3.6.1 Discussion of patient sex 
The most frequent theme surrounding discussion of patients’ sex was whether 
the trainee found it appropriate to tailor and individualize treatment based on sex. 
Trainees who were aware of their decision-making influences were more likely to 
discuss being uncomfortable using different treatments based solely on patients’ sex, 
unless there was evidence for tailoring treatments, e.g., “[I]f there are studies that 
show…women work better with certain medications than men, then if there’s evidence 
that backs it up, I’d be willing to try it” (Participant 22, Aware). This discussion is 
interesting in light of the fact that the majority of aware providers were more likely to 
both consistently use and report using patient demographics. Thus, although trainees 
discuss the necessity of evidence-based support to tailor treatments based on patients’ 
sex, they were statistically influenced by patient sex in their online treatment decisions. 
However, unaware trainees were more likely to discuss that there are differences in risk 
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factors between men and women that would make tailoring more appropriate, e.g., 
“[P]retending a women’s risk factor for depression is the same as a man’s is not 
medically sound. Women are at a higher risk for depression…so I think really you 
incorporate the sex into their clinical picture.” (Participant 14, Unaware). This discussion 
mirrors part of the quantitative findings that the majority of unaware trainees were 
more likely to report using patient demographics; however, these trainees were not 
statistically influenced by patient demographics in statistical analyses.  
The second most common theme was differences in patients’ presentation and 
description of their chronic pain. A typical response of trainees, regardless of level of 
awareness, related to patients’ description of pain, e.g., “[M]en are more linked to 
injury of a specific work environment whereas women seem to have more generalized 
pain issues.”  (Participant 10, Aware trainee). Trainees also commented on differences 
in presentation, e.g., “The women are more emotional with it. They’re the ones that 
typically start break down and crying in the room; where the men kind of hide it and 
don’t want to kind of show that this is a weakness in their life so they don’t really talk 
about it. They just want a solution.” (Participant 11, Unaware).  
 
3.6.2 Discussion of patient race 
The majority of trainees discussed differences in description and presentation of 
pain between ethnic, but not racial, groups. Aware trainees did not recognize any 
differences between Black and White pain patients, e.g., “Between African-American 
and Caucasians, I am not really sure that there is any difference in presentation” 
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(Participant 21, Aware). However, aware trainees discussed differences between 
Hispanic patients and other racial/ethnic groups. Discussions typically centered on 
beliefs about cultural differences, such as differences in how Hispanic patients present 
with pain, e.g., “I just think that Latinos, they come quicker and they have sometimes 
minor pain….” (Participant 21, Aware). One trainee expressed frustration with this 
stereotype, “I’ve heard a lot of my colleagues discuss the Hispanic population as having 
like silly complaints…I feel like they’re being overly dismissive of the Hispanic abdominal 
pain complaints…” (Participant 1, Aware). The trainee then noted, “I feel like that 
attitude has probably influenced how I’m seeing patients because…I try to filter out the 
fact that I’ve heard [and] read about biases in medicine” (Participant 1, Aware). 
Similarly trainees who demonstrated a lack of concordance between reported 
and actual use of demographics did not discuss any differences between Black and 
White chronic pain patients, e.g., “African-American or Caucasian…they’re pretty similar. 
When they’re in pain, they present like they’re in pain…there’s really no difference 
between those two” (Participant 3, Unaware). Unaware trainees also discussed Hispanic 
patients’ pain presentations, specifically that Hispanic individuals view pain as a “part of 
daily life” and do not “manifest pain” as much as other race/ethnicities (Participant 2, 
Unaware). Discussion of Hispanic population’s pain was summed up plainly by one 
trainee: “As a rule, the Hispanic population does not have chronic pain” (Participant 14, 
Unaware). Thus, aware and unaware trainees were willing to discuss unique aspects of 
the Hispanic patient’s experiences with chronic pain. Aware trainees were consistently 
more likely to comment on Hispanic patients presenting quickly to hospitals when in 
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pain; whereas, unaware trainees typically commented that Hispanic patients rarely 
present or express pain. However across both groups, there was very little discussion 
regarding perceived differences between Black and White patients’ pain experiences or 
how patients’ race may influence their treatment decisions.  
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CHAPTER 4. DISCUSSION 
 
Female and Black individuals are at increased risk for sub-optimal pain care, which 
may be related to differences in providers’ pain decisions and/or their gender and racial 
attitudes. Additionally, it is unclear whether providers are aware of the factors, such as 
patient sex and race, which influence their pain treatment decisions. Using novel virtual 
human technology and lens model methodology, this study found that half of the 
trainees sampled were reliably influenced by patient demographics when making 
treatment decisions, and the majority of these trainees were generally aware of this 
influence. Trainees’ racial attitudes – specifically, their complimentary stereotypes 
about Black individuals – were positively associated with their opioid recommendations 
for White chronic pain patients. During interviews, trainees discussed differences in pain 
presentation and description based on patient sex and ethnicity. Trainees’ discussions 
were generally consistent regardless of their decision-making awareness.  
In line with my first hypothesis, almost half of the trainees (40%) were influenced by 
patient sex in their treatment decisions. However, at the group-level, no significant sex 
differences in treatment ratings were detected. At the idiographic level of analysis, 
patient sex was most influential for opioid ratings, with 4 (out of 20) trainees 
consistently using patient sex in their opioid ratings; three of which gave higher opioid 
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ratings to male patients. Furthermore, patient sex accounted for an average of 7% of 
the variance in trainees’ opioid treatment ratings. Thus, although patients’ sex was not a 
consistently strong predictor overall in trainees’ treatment decisions, it was reliably 
used by some providers. These individual differences are typically overlooked in 
traditional group-based analyses. Considering the prevalence of chronic pain and 
frequency of healthcare utilization among this patient population (1), as well as sex 
differences in rates of different pain conditions (54), accounting for individual 
differences in clinical decision-making can allow researchers to better isolate provider-
related factors that may contribute to treatment disparities and help develop effective 
educational interventions. 
Trainees were also influenced by patient race. As hypothesized, group 
differences emerged with White patients receiving higher antidepressant ratings than 
Black patients. This aligns with recent findings that Black patients with depression are 
less likely than White depressed patients to be treated with antidepressants (82). 
Although non-significant, there were small-to-moderate effect sizes for Black patients to 
receive higher opioid and referral to pain specialist ratings than White patients. These 
findings are not consistent with the majority of published retrospective investigations, 
which found Black patients received significantly less opioid medication for their pain 
than White patients (78-80). However, other vignette pain studies have found similar 
opioid treatment recommendations for Black pain patients (see 32, 70, 141). A possible 
explanation for these inconsistencies in the literature is that patient race may serve as a 
proxy variable for true variables that influence providers, such as patients’ SES and 
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access to care.  These patient factors, which are typically confounded with race, are 
often unmeasured in retrospective study designs but may be controlled in vignette 
study designs. Indeed, some trainees noted that patients’ SES is often confounded with 
race, e.g., “I don’t think there is a difference amongst races [presenting in pain to the 
hospital]. It’s more socioeconomic status and in this area it seems that the lower 
socioeconomic status that I’ve seen in the hospital is usually an African-American or 
Hispanic patient…” (Participant 6, Aware). Some trainees noted patient SES is more 
likely to influence their decisions than race, e.g., “[My treatment decision] factors in on 
the economic status too. So race alone…wouldn’t be enough to change the treatment” 
(Participant 10, Aware). Often discussed were issues due to access to care, insurance 
status, and transportation difficulties. These factors were not systematically 
manipulated in the current study; thus, it was not possible to examine their influence on 
participants’ treatment decisions. Future investigations should manipulate additional 
patient factors with patient demographics, such as issues surrounding low SES, to 
examine the unique and combined influence of these factors on treatment decisions.  
At the group-level, White patients received significantly higher antidepressant 
ratings than Black patients; however, at the idiographic level, no trainee was reliably 
influenced by patient race in their antidepressant recommendations. Although these 
seem to contradict each other, nonsignificant differences at the idiographic level can 
add up to significant differences at the nomothetic level. These findings suggest that, 
rather than antidepressant treatment differences being driven by a small number of 
trainees, the majority of trainees sampled gave slightly higher antidepressant ratings to 
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White than Black patients. The clinical implications of this interpretation are unclear at 
this time. Additional research is needed to better understand how providers use 
antidepressants for diverse patient with chronic pain and the effects of even small 
variation in treatment decisions for different patients. 
Trainees demonstrated greater awareness of their decision-making influences 
than hypothesized and found in previous work (32, 142-144). However, qualitative 
results did not differ considerably between concordant (“aware”) and discordant 
(“unaware”) trainees. While the quantitative measure of awareness indicated that the 
majority of aware trainees were both influenced by and reported use of patient 
demographics, trainees in this group discussed being uncomfortable tailoring 
treatments based on patients’ sex. This apparent contradiction between trainees’ 
quantitative and qualitative findings could be due to several factors. First, providers 
were asked to report their use of “patient demographics,” which may be too broad of a 
category; providers may be more or less aware of being influenced by a specific patient 
demographic variable such as sex or race. Furthermore, this question included “age” as 
a demographic characteristic for consideration. Trainees may have endorsed using 
patients’ demographics but were more aware of being influenced by patients’ age, as 
opposed to sex or race. Secondly, trainees may feel comfortable reporting demographic 
influences in anonymous online formats, but be uncomfortable discussing these 
influences in face-to-face interviews due to social desirability.  
Nevertheless, trainees were relatively candid in their discussion of Hispanic 
patients’ presentations of chronic pain. The interviews uncovered a range of attitudes 
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toward Hispanic patients -- from Hispanic individuals do not experience chronic pain to 
Hispanic patients present too frequently with uncommon pain complaints. Future 
investigations should examine how providers’ attitudes about Hispanic patients may 
influence their pain care. This is particularly important as the Hispanic population in 
recent years has become the fastest growing demographic group (145), and this 
population is over-represented in occupations that put individuals at an increased risk of 
developing chronic pain (146-149). 
Contrary to my third hypothesis, trainees’ gender and racial attitudes were not 
significantly associated with their treatment for female and Black patients, respectively. 
However, trainees’ complimentary racial attitudes were associated with their opioid 
ratings for White patients. One aspect of the complimentary stereotypes assessed on 
the racial attitude measure is that Black persons are more athletic than White 
individuals (138). These “positive” stereotypes about Black persons’ physical capabilities 
may result in providers’ believing Black patients have a higher pain tolerance than White 
persons. Similarly, a recent investigation found laypersons rated a typical White person 
as being more sensitive to pain than the typical Black person (65). However, given the 
lack of literature to support this relationship, this finding should be interpreted with 
caution. This interpretation would be strengthened if racial attitudes had also been 
found to be negatively associated with Black patients’ opioid ratings.  
There are other potential clinical and research implications of this study. This 
investigation builds upon previous disparities work by using rigorous and clinically 
relevant methodology. Half of sampled trainees were influenced by patient sex or race 
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in their treatment decisions, which suggests that early and continued attention to 
identifying and reducing pain disparities during medical training is needed.  While 
trainees demonstrated some awareness of their decision-making influences, medical 
curricula could focus on enhancing all trainees’ awareness of their treatment decision 
influences, which will likely improve patient care, particularly for ambiguous and 
emotionally-charged medical conditions like chronic pain. Furthermore, trainees 
expressed some negative attitudes, both on validated measures and during interviews, 
about female and Black chronic pain patients. Efforts that directly intervene on these 
attitudes during medical training and continuing education may help reduce treatment 
disparities.  
Future research on disparities and awareness may want to consider the 
following recommendations. Given the inconsistent literature on treatment disparities, 
more research is needed to better understand variability in pain treatment across 
patient sexes and races. Future investigations should examine provider awareness of 
being influenced by patient sex and race, separately, as awareness may vary between 
these two patient factors. Additionally, the role of other provider attitudes, including 
implicit attitudes, attitudes towards socioeconomic status, and attitudes towards 
Hispanic individuals, should be investigated to examine their role in unequal pain 
management. Furthermore, given the qualitative results of the current study and the 
relative dearth of research on pain in Hispanic individuals, future research is needed to 
better understand the pain experiences of Hispanic patients, as well as providers’ 
attitudes and treatment practices with this rapidly growing population. Additionally, 
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shared decision-making may be important to examine in the treatment of chronic pain, 
particularly when patients and providers have different demographic characteristics.  
Some limitations of this study should be addressed. Although the VH technology 
has been used successfully in previous studies, with participants rating the vignettes as 
realistic and reflective of actual clinical scenarios (30, 31), one should be cautious when 
generalizing these findings to actual clinical practice.  Although patient vignettes give 
researchers more experimental control than trained actors, they do create an artificial 
environment that may not reflect an actual clinical setting. In addition, this study used 
self-report attitude measures and individual interviews, which may be susceptible to 
participants providing socially desirable answers. This concern may be particularly 
relevant to the current study, as trainees were interviewed after completing the online 
study, and the majority of trainees’ guessed correctly at the study’s hypotheses/purpose. 
Based on the a priori power analysis, group-analyses may just reach adequate power 
with 20 participants. However, this lens model study used a favorable profile to cue 
ratio (8:1, which exceeds the suggested 5:1) and included 4 replications of each cue 
combination, which enhances power based on the increased number of ratings across 
cues. Finally, this study included a limited number of healthcare trainees from a mid-
western medical school, which may limit the generalizability of these findings to other 
healthcare provider trainees and types, as well as those in other parts of the country. 
In summary, this investigation used novel mixed methodology to better 
understand trainees’ chronic pain treatment decision-making and the influence of 
patient sex and race on their decisions. Patient sex or race was influential in half of the 
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trainee’s decisions for recommending opioids, antidepressants, physical therapy, or 
referral to a pain specialist.  Trainees’ demonstrated some awareness of the influence 
patient demographics had on their decision-making process. Although certain types of 
explicit racial attitudes appear to be associated with trainees’ opioid treatment 
decisions for White patients, sex- and race-related attitudes were not prominently 
related to trainees’ treatment decisions. Additionally, qualitative interviews 
supplemented the quantitative findings, specifically in regards to trainees’ awareness 
and attitudes. Future investigations should include additional patient factors to examine 
possible mediators and moderators of pain treatment disparities. 
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Appendix A 
Please follow these instructions and those on the following pages very carefully. 
Instructions for completing online study 
Prior to making your ratings, you must: 
• Read each patient's clinical summary fully and carefully 
• Review each patient's vital sign information fully and carefully 
• View each patient's image 
For each patient, you will be asked to: 
• Rate the level of pain this patient has been experiencing 
• Rate the level of psychological distress this patient has been experiencing 
For each patient, you will also be asked to: 
• Rate the likelihood that you would consider/recommend the pain management 
practices listed below in the care of this patient. - Prescription of opioid/narcotic pain medication* - Prescription of non-opioid/non-narcotic pain medication - Prescription of antidepressant medication* - Over-the-counter pain medication - Lifestyle activities such as diet and/or exercise - Physical therapy* - Ice, heat, and/or analgesic cream - Referral to a mental health provider for counseling - Referral to a pain specialist* - No intervention at this time; return in 1 month 
*This investigation examined 4 out of the 10 treatment 
considerations/recommendations 
Each of your ratings will be made on scales consisting of a horizontal line and "slider" 
that you can adjust to indicate the point on the line that best represents your rating. To 
make your ratings: 
• Place your mouse cursor over the "slider" 
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• While holding the left mouse button down, move the slider to the point on the 
line that represents your rating 
When making your ratings, it is important that you only use the information provided on 
the screen, and that you not think about previous patients and ratings you have already 
completed. 
 
You must complete all of the ratings for a given patient before moving onto the next 
patient. When you have completed your ratings for a patient, click the "next" button at 
the bottom of screen to move onto the next patient. 
  
92 
 
Appendix B 
1)  Age: _____    
Demographics questionnaire 
2)  Sex:  Male    Female   
3)  Race/Ethnicity          
 Asian/Pacific Islander 
 Black/African American 
 Hispanic/Latino  
 Native American/Eskimo/Aleut  
 White/Caucasian    
 Other (please specify) __________  
4)  In what state do you currently live? [Drop down box listing the states] 
5)  Are you currently a student in an undergraduate psychology course? 
No (please skip the next question and proceed to question 7) 
Yes (please answer the next question) 
 
6)  What is your current class standing? 
Freshman 
Sophomore 
Junior 
Senior 
Other (please specify) __________ 
 
7)  Are you currently in a training program to be a healthcare provider? 
No (please skip the next question and proceed to question 9) 
Yes (please answer the next question)   
 
8)  What type of training program are you currently in? 
Undergraduate nursing 
Undergraduate medical 
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Graduate nursing  
Medical residency  
Medical fellowship    
Other (please specify) __________ 
 
9)  Are you currently a practicing healthcare provider? 
No (please skip questions 10-14 and proceed to question 15) 
Yes (please answer the remaining questions) 
 
10)  What type of healthcare provider are you (select the one that most applies)? 
Physician (not a Resident or Fellow) 
Physician (Resident or Fellow) 
Advanced Practice Provider (e.g., Physician Assistant, Advanced 
Practice Nurse) 
Registered Nurse 
 
11)  Years of professional healthcare experience (do not include time spent in training): 
____ 
12)  Current practice setting (select the one that most applies) 
Hospital 
Nursing Home 
Hospice 
Outpatient clinic 
Emergency Room/Urgent Care 
Other (please specify) __________      
 
13)  Current clinical specialty (select the one that most applies) 
Anesthesiology   
Critical Care 
Emergency Medicine  
Family Medicine 
Gastroenterology 
Internal Medicine  
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Neurology   
Obstetrics/Gynecology 
Oncology    
Orthopedics   
Pediatrics 
Physical Medicine and Rehabilitation 
Primary Care 
Psychiatry 
Rheumatology 
Surgery 
Other (please specify) __________ 
 
14)  Rate your level of clinical experience with chronic pain 
Not at all experienced _______________________________________ Very experienced 
 
15)  Rate your level of personal experience (self and/or others) with chronic pain 
Not at all experienced _______________________________________ Very experienced 
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Appendix C 
Below is a series of statements concerning men and women and their relationships in 
contemporary society. Please indicate the degree to which you agree or disagree with each 
statement.  
Ambivalent Sexism Inventory 
 
1. No matter how accomplished he is, a man is not truly complete as a person unless he has the 
love of a woman. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
2. Many women are actually seeking special favors, such as hiring policies that favor them over 
men, under the guise of asking for "equality." 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
3. In a disaster, women ought not necessarily to be rescued before men. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
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4. Most women interpret innocent remarks or acts as being sexist. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
5. Women are too easily offended. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
6. People are often truly happy in life without being romantically involved with a member of the 
other sex. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
7. Feminists are not seeking for women to have more power than men. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
8. Many women have a quality of purity that few men possess. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
 
97 
 
9. Women should be cherished and protected by men. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
10. Most women fail to appreciate fully all that men do for them. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
11. Women seek to gain power by getting control over men. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
12. Every man ought to have a woman whom he adores. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
13. Men are complete without women. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
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14. Women exaggerate problems they have at work. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
15. Once a woman gets a man to commit to her, she usually tries to put him on a tight leash. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
16. When women lose to men in a fair competition, they typically complain about being 
discriminated against. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
17. A good woman should be set on a pedestal by her man. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
18. There are actually very few women who get a kick out of teasing men by seeming sexually 
available and then refusing male advances. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
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19. Women, compared to men, tend to have a superior moral sensibility. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
20. Men should be willing to sacrifice their own well being in order to provide financially for the 
women in their lives. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
21. Feminists are making entirely reasonable demands of men. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
 
22. Women, as compared to men, tend to have a more refined sense of culture and good taste. 
      
0 1 2 3 4 5 
disagree 
strongly 
disagree 
somewhat 
disagree 
slightly 
agree 
slightly 
agree 
somewhat 
agree 
strongly 
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Appendix D 
Please indicate your level of agreement with the items below. 
Complementary Stereotypes and Negative Prejudice Scale 
1. There are so many Black criminals because Black people are naturally more aggressive. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
2. Black people do not have a natural “instinct” for athletics. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
3. Housing laws should be passed that encourage greater racial integration of 
neighborhoods. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
4. A Black person is wasting an opportunity by not getting involved in athletics. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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5. I think the way Black people talk and the expressions they use are cool. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
6. The success of Black athletes has nothing to do with their natural ability. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
7. Black people often have a difficult time picking up the beat to music. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
8. Black people have a unique quality of sexuality that most White people don’t have. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
9. There will always be racial differences in intelligence. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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10. I think it would be fun to have a Black roommate. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
11. There are so many Black athletes in professional sports because of their innate 
ability. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
12. Black people should learn to work hard rather than look for “freebies” and 
“handouts.” 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
13. Black people usually aren’t very stylish in their appearance. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
14. A natural sense of rhythm makes rapping easy for Black people. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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15. Affirmative Action is not just reverse discrimination against White people. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
16. As a whole, White people aren’t smarter than Black people. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
17. The welfare system really just allows Black people to “mooch” money from the 
government. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
18. It’s just not natural to see a Black person and a White person holding hands and 
kissing. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
19. It’s true that White men really can’t jump as well as Black men. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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20. Black people could be as successful as White people if they only worked harder. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
21. Most Black people have a sense of coolness that White people don’t have. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
22. White people lose a lot of jobs to Black people because of racial quotas in hiring 
processes. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
23. Black men and women give off an aura of sensuality. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
24. I can’t understand why a White person would want to date a Black person. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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25. When music starts playing, I expect Black people to start moving to the beat. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
26. White choirs put on a much better performance than Black choirs. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
27. I would have no problems with dating a Black person. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
28. Black people should take advantage of their natural abilities to sing and dance. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
 
29. The government is already spending too much time catering to the wishes of Black 
people. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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30. I enjoy groups that are racially diverse. 
                   
1  2  3  4  5  6         7  
Strongly           Strongly 
Disagree           Agree 
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Appendix E 
Please select the information you used when making your pain assessment and 
treatment ratings for the patients (check all that apply). For each item that you select, 
rate how influential it was, on average, to your pain ratings. Use the slider to indicate 
the level of influence. 
Information used questionnaire 
 
1. Pain history (e.g., duration of pain, cause of pain, prior treatment) 
Minimal influence ______________________________________ Maximal influence 
 
2. Patients’ description of the pain (e.g., location, level of interference with activities) 
Minimal influence ______________________________________ Maximal influence 
 
3. Patients’ facial expressions 
Minimal influence ______________________________________ Maximal influence 
 
4. Patients’ demographic characteristics (e.g., sex, race, age) 
Minimal influence _____________________________________ Maximal influence 
 
5. Patients’ vital sign values 
Minimal influence ______________________________________ Maximal influence 
 
6. Patients’ movement 
Minimal influence ______________________________________ Maximal influence 
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7. Patients’ mental health symptoms  
Minimal influence ______________________________________ Maximal influence 
 
8. Your own personal experience in managing and/or interacting with patients with 
pain 
Minimal influence ______________________________________ Maximal influence 
 
9. Your intuition 
Minimal influence ______________________________________ Maximal influence 
 
10. Other (please explain): __________ 
Minimal influence ______________________________________ Maximal influence 
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Appendix F 
In the box below, please indicate what you think is the purpose(s) of this study? 
Guess at study purpose 
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Appendix G 
Thank you for speaking with me today. [Introduce yourself and describe your role in 
the project.] This interview will include mostly open-ended (discussion) type questions. 
If you want clarification on any question, feel free to ask. 
Interview guide 
I want to be sure you understand that what I hear and collect from you will be 
confidential.  Your answers and quotes may be used in presentations and publications, 
but your name and other identifiers will not be used.  We are going to record this 
session and transcribe our discussion today. The only people who will have access to 
this information are the project investigators and the transcriptionist. Is that okay with 
you? Do you have any questions before we begin? [When no, turn on the recorder and 
record ID information on tape; include date, time, participant ID, and your name]. 
 
1. How do you decide what treatments to use for patients with chronic pain?  What 
factors influence your decision making? Are there any particular treatments you feel 
most comfortable using or any that you avoid? 
• [Make sure subject discusses both aspects (comfortable and avoid).] 
• [If only one type of treatment is discussed (e.g., opioids), probe for others.] 
• [If reply is to refer to others, probe for whom and why.] 
 
2. On this card is a list of several chronic pain treatments. Which of these stand out 
to you and why? 
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• Opioid/narcotic pain medications 
• Non-opioid/non-narcotic pain medications [prescription NSAIDs such as 
meloxicam (Mobic), etodolac (Lodine), nabumetone (Relafen)] 
• Antidepressant medication [e.g. amitriptyline (Elavil), nortriptyline (Pamelor), 
duloxetine (Cymbalta), venlafaxine (Effexor)] 
• Over-the-counter pain medication  
• Lifestyle activities such as diet or exercise  
• Physical therapy  
• Ice, heat, or analgesic cream  
• Referral to a mental health provider for counseling  
• Referral to a pain specialist 
• [Probe: which would/do you use most often? Least often?] 
 
3. How do you decide what types of pain treatments to use for particular patients? 
• Are there certain treatments you avoid for particular patients? Why? 
 
4. For each of the different pain treatments, in what types of patients are you most 
likely to use these treatments? 
• What other patient factors influence your treatment decision? 
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5. How frequently do you see depression in patients with chronic pain? 
• Does the presence of depression influence your opinions about pain treatment? 
 
6. How diverse are the patients you see? 
• [Probes: men/women, young/old, racial and ethnic diversity] 
 
7. In thinking about the diversity of patients with chronic pain, what kinds of 
differences have you noticed between men and women? 
• [Probes: differences in how they present, differences in the types of treatments 
you use, differences in how they respond to treatment] 
• What are your thoughts about tailoring pain treatment for patients based on 
their sex? 
 
8. Have you noticed differences between pain patients of different socioeconomic 
levels? 
• [Probes: differences in how they present, differences in the types of treatments 
you use, differences in how they respond to treatment] 
• [Probes: high SES patients] 
• [Probes: transportation difficulties, keeping appointments with you or other 
providers, paying for medications and other treatments, problems with drug diversion 
or having drugs stolen] 
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9. Have you noticed differences between patients of different races/ethnicities? 
• [Probes: differences in how they present, differences in the types of treatments 
you use, differences in how they respond to treatment] 
• [Probe for other race and ethnic groups; including Caucasian] 
 
10. How often do you think incorrect or inappropriate use of pain treatments is a 
problem?  
• For what types of patients is this more of a problem? 
• [Probe for other treatments if only opioids are discussed.] 
 
11. Any additional thoughts or comments about chronic pain that you would like to 
share? 
